| Name |
|---|
HIVEP1 Genehuman immunodeficiency virus type I enhancer binding protein 1 This gene encodes a transcription factor belonging to the ZAS family, members of which are large proteins that contain a ZAS domain - a modular protein structure consisting of a pair of C2H2 zinc fingers with an acidic-rich region and a serine/threonine-rich sequence. These proteins bind specifically to the DNA sequence motif, GGGACTTTCC, found in the enhancer elements of several viral promoters, including human immunodeficiency virus (HIV), and to related sequences found in the enhancer elements of a number of cellular promoters. This protein binds to this sequence motif, suggesting a role in the transcriptional regulation of both viral and cellular genes. [provided by RefSeq, Oct 2011] |
HIVEP2 Genehuman immunodeficiency virus type I enhancer binding protein 2 This gene encodes a member of a family of closely related, large, zinc finger-containing transcription factors. The encoded protein regulates transcription by binding to regulatory regions of various cellular and viral genes that maybe involved in growth, development and metastasis. The protein contains the ZAS domain comprised of two widely separated regions of zinc finger motifs, a stretch of highly acidic amino acids and a serine/threonine-rich sequence. [provided by RefSeq, Nov 2012] |
HIVEP3 Genehuman immunodeficiency virus type I enhancer binding protein 3 This gene encodes a member of the human immunodeficiency virus type 1 enhancer-binding protein family. Members of this protein family contain multiple zinc finger and acid-rich (ZAS) domains and serine-threonine rich regions. This protein acts as a transcription factor and is able to regulate nuclear factor kappaB-mediated transcription by binding the kappaB motif in target genes. This protein also binds the recombination signal sequence that flanks the V, D, and J regions of immunoglobulin and T-cell receptors. Alternate splicing results in both coding and non-coding transcript variants. [provided by RefSeq, Sep 2011] |
TRAV23DV6 GeneT cell receptor alpha variable 23/delta variable 6 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV29DV5 GeneT cell receptor alpha variable 29/delta variable 5 (gene/pseudogene) T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV14DV4 GeneT cell receptor alpha variable 14/delta variable 4 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV36DV7 GeneT cell receptor alpha variable 36/delta variable 7 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV38-2DV8 GeneT cell receptor alpha variable 38-2/delta variable 8 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
FRA4A Genefragile site, aphidicolin type, common, fra(4)(p16.1) |
FRA4B Genefragile site, BrdU type, common, fra(4)(q12) |
FRA4C Genefragile site, aphidicolin type, common, fra(4)(q31.1) |
FRA4D Genefragile site, aphidicolin type, common, fra(4)(p15) |
FRA22B Genefragile site, aphidicolin type, common, fra(22)(q12.2) |
FRA17B Genefragile site, aphidicolin type, common, fra(17)(q23.1) |
C3CER1 Genechromosome 3 common eliminated region 1 |
FRA7I Genefragile site, aphidicolin type, common, fra(7)(q36) |
FRA7H Genefragile site, aphidicolin type, common, fra(7)(q32.3) |
FRA7J Genefragile site, aphidicolin type, common, fra(7)(q11) |
FRA7C Genefragile site, aphidicolin type, common, fra(7)(p14.2) |
FRA7B Genefragile site, aphidicolin type, common, fra(7)(p22) |
FRA7E Genefragile site, aphidicolin type, common, fra(7)(q21.2) |
FRA7D Genefragile site, aphidicolin type, common, fra(7)(p13) |
FRA7G Genefragile site, aphidicolin type, common, fra(7)(q31.2) |
FRA7F Genefragile site, aphidicolin type, common, fra(7)(q22) |
FRA10D Genefragile site, aphidicolin type, common, fra(10)(q22.1) |
FRA10E Genefragile site, aphidicolin type, common, fra(10)(q25.2) |
FRA10F Genefragile site, aphidicolin type, common, fra(10)(q26.1) |
FRA10G Genefragile site, aphidicolin type, common, fra(10)(q11.2) |
FRA10C Genefragile site, BrdU type, common, fra(10)(q21) |
FRA2F Genefragile site, aphidicolin type, common, fra(2)(q21.3) |
FRA2G Genefragile site, aphidicolin type, common, fra(2)(q31) |
FRA2D Genefragile site, aphidicolin type, common, fra(2)(p16.2) |
FRA2E Genefragile site, aphidicolin type, common, fra(2)(p13) |
FRA2C Genefragile site, aphidicolin type, common, fra(2)(p24.2) |
FRA2J Genefragile site, aphidicolin type, common, fra(2)(q37.3) |
FRA2H Genefragile site, aphidicolin type, common, fra(2)(q32.1) |
FRA2I Genefragile site, aphidicolin type, common, fra(2)(q33) |
FRA18A Genefragile site, aphidicolin type, common, fra(18)(q12.2) |
FRA18B Genefragile site, aphidicolin type, common, fra(18)(q21.3) |
FRA15A Genefragile site, aphidicolin type, common, fra(15)(q22) |
NIDDM2 Genenon-insulin-dependent diabetes mellitus (common, type 2) 2 |
NIDDM1 Genenon-insulin-dependent diabetes mellitus (common, type 2) 1 |
FRA5F Genefragile site, aphidicolin type, common, fra(5)(q21) |
FRA5E Genefragile site, aphidicolin type, common, fra(5)(p14) |
FRA5D Genefragile site, aphidicolin type, common, fra(5)(q15) |
FRA5C Genefragile site, aphidicolin type, common, fra(5)(q31.1) |
FRA5B Genefragile site, BrdU type, common, fra(5)(q15) |
FRA5A Genefragile site, BrdU type, common, fra(5)(p13) |
FRA16D Genefragile site, aphidicolin type, common, fra(16)(q23.2) |
FRA16C Genefragile site, aphidicolin type, common, fra(16)(q22.1) |
FRA8D Genefragile site, aphidicolin type, common, fra(8)(q24.3) |
FRA8B Genefragile site, aphidicolin type, common, fra(8)(q22.1) |
FRA8C Genefragile site, aphidicolin type, common, fra(8)(q24.1) |
FRA13A Genefragile site, aphidicolin type, common, fra(13)(q13.2) |
FRA13C Genefragile site, aphidicolin type, common, fra(13)(q21.2) |
FRA13B Genefragile site, BrdU type, common, fra(13)(q21) |
FRA13D Genefragile site, aphidicolin type, common, fra(13)(q32) |
FRA3D Genefragile site, aphidicolin type, common, fra(3)(q25) |
FRA3C Genefragile site, aphidicolin type, common, fra(3)(q27) |
FRA18C Genefragile site, aphidicolin type, common, fra(18)(q22.2) |
FRAXD Genefragile site, aphidicolin type, common, fra(X)(q27.2) D |
FRAXB Genefragile site, aphidicolin type, common, fra(X)(p22.31) B |
FRAXC Genefragile site, aphidicolin type, common, fra(X)(q22.1) C |
FRA14B Genefragile site, aphidicolin type, common, fra(14)(q23) |
FRA14C Genefragile site, aphidicolin type, common, fra(14)(q24.1) |
FRA6B Genefragile site, aphidicolin type, common, fra(6)(p25.1) |
FRA6C Genefragile site, aphidicolin type, common, fra(6)(p22.2) |
FRA6F Genefragile site, aphidicolin type, common, fra(6)(q21) |
FRA6G Genefragile site, aphidicolin type, common, fra(6)(q15) |
FRA6D Genefragile site, BrdU type, common, fra(6)(q13) |
FRA6E Genefragile site, aphidicolin type, common, fra(6)(q26) |
FRA3A Genefragile site, aphidicolin type, common, fra(3)(p24.2) |
FRA11C Genefragile site, aphidicolin type, common, fra(11)(p15.1) |
FRA11G Genefragile site, aphidicolin type, common, fra(11)(q23.3) |
FRA11F Genefragile site, aphidicolin type, common, fra(11)(q14.2) |
FRA11E Genefragile site, aphidicolin type, common, fra(11)(p13) |
FRA11D Genefragile site, aphidicolin type, common, fra(11)(p14.2) |
FRA11H Genefragile site, aphidicolin type, common, fra(11)(q13) |
FRA1C Genefragile site, aphidicolin type, common, fra(1)(p31.2) |
FRA1B Genefragile site, aphidicolin type, common, fra(1)(p32) |
FRA1A Genefragile site, aphidicolin type, common, fra(1)(p36) |
FRA1G Genefragile site, aphidicolin type, common, fra(1)(q25.1) |
FRA1F Genefragile site, aphidicolin type, common, fra(1)(q21) |
FRA1E Genefragile site, aphidicolin type, common, fra(1)(p21.2) |
FRA1D Genefragile site, aphidicolin type, common, fra(1)(p22) |
FRA1K Genefragile site, aphidicolin type, common, fra(1)(q31) |
FRA1J Genefragile site, 5-azacytidine type, common, fra(1)(q12) |
FRA1I Genefragile site, aphidicolin type, common, fra(1)(q44) |
FRA1H Genefragile site, 5-azacytidine type, common, fra(1)(q42) |
FRA1L Genefragile site, aphidicolin type, common, fra(1)(p31) |
FRA12B Genefragile site, aphidicolin type, common, fra(12)(q21.3) |
FRA19A Genefragile site, 5-azacytidine type, common, fra(19)(q13) |
FRA20B Genefragile site, aphidicolin type, common, fra(20)(p12.2) |
FRA9C Genefragile site, BrdU type, common, fra(9)(p21) |
FRA9F Genefragile site, 5-azacytidine type, common, fra(9)(q12) |
FRA9E Genefragile site, aphidicolin type, common, fra(9)(q32) |
FRA9D Genefragile site, aphidicolin type, common, fra(9)(q22.1) |
ACYP1 Geneacylphosphatase 1, erythrocyte (common) type This gene is a member of the acylphosphatase family. The encoded protein is a small cytosolic enzyme that catalyzes the hydrolysis of the carboxyl-phosphate bond of acylphosphates. Two isoenzymes have been isolated and described based on their tissue localization: erythrocyte (common) type acylphosphatase encoded by this gene, and muscle type acylphosphatase. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2014] |
FRA12E Genefragile site, aphidicolin type, common, fra(12)(q24) |
IGLVI-38 Geneimmunoglobulin lambda variable (I)-38 (pseudogene) |
IGKV1OR10-1 Geneimmunoglobulin kappa variable 1/OR10-1 (pseudogene) |
IGHVII-60-1 Geneimmunoglobulin heavy variable (II)-60-1 (pseudogene) |
IGHV1-8 Geneimmunoglobulin heavy variable 1-8 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV1-3 Geneimmunoglobulin heavy variable 1-3 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV1-2 Geneimmunoglobulin heavy variable 1-2 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV4-4 Geneimmunoglobulin heavy variable 4-4 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1-12 Geneimmunoglobulin kappa variable 1-12 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1-16 Geneimmunoglobulin kappa variable 1-16 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1-17 Geneimmunoglobulin kappa variable 1-17 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle and extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV5-78 Geneimmunoglobulin heavy variable 5-78 (pseudogene) |
TRBV20-1 GeneT cell receptor beta variable 20-1 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV1-36 Geneimmunoglobulin lambda variable 1-36 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV2-36 Geneimmunoglobulin kappa variable 2-36 (pseudogene) |
IGKV2-30 Geneimmunoglobulin kappa variable 2-30 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle and extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV2-38 Geneimmunoglobulin kappa variable 2-38 (pseudogene) |
IGHVIII-26-1 Geneimmunoglobulin heavy variable (III)-26-1 (pseudogene) |
IGHV1-69-2 Geneimmunoglobulin heavy variable 1-69-2 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV1-45 Geneimmunoglobulin heavy variable 1-45 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV1-38-4 Geneimmunoglobulin heavy variable 1-38-4 (non-functional) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV2OR2-8 Geneimmunoglobulin kappa variable 2/OR2-8 (pseudogene) |
IGKV2D-14 Geneimmunoglobulin kappa variable 2D-14 (pseudogene) |
IGKV2D-10 Geneimmunoglobulin kappa variable 2D-10 (pseudogene) |
IGKV2D-18 Geneimmunoglobulin kappa variable 2D-18 (pseudogene) |
IGKV2D-19 Geneimmunoglobulin kappa variable 2D-19 (pseudogene) |
TRBV6-8 GeneT cell receptor beta variable 6-8 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV6-9 GeneT cell receptor beta variable 6-9 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV6-5 GeneT cell receptor beta variable 6-5 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV6-6 GeneT cell receptor beta variable 6-6 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV6-7 GeneT cell receptor beta variable 6-7 (non-functional) Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV6-2 GeneT cell receptor beta variable 6-2 (gene/pseudogene) Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV6-3 GeneT cell receptor beta variable 6-3 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV21-1 GeneT cell receptor beta variable 21-1 (pseudogene) |
IGHV3OR16-7 Geneimmunoglobulin heavy variable 3/OR16-7 (pseudogene) |
IGHV3-69-1 Geneimmunoglobulin heavy variable 3-69-1 (pseudogene) |
TRBV23OR9-2 GeneT cell receptor beta variable 23/OR9-2 (non-functional) |
IGLV5-45 Geneimmunoglobulin lambda variable 5-45 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV5-48 Geneimmunoglobulin lambda variable 5-48 (non-functional) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV30 GeneT cell receptor beta variable 30 (gene/pseudogene) Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
IGHVII-22-1 Geneimmunoglobulin heavy variable (II)-22-1 (pseudogene) |
IGKV3-11 Geneimmunoglobulin kappa variable 3-11 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle and extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV3-15 Geneimmunoglobulin kappa variable 3-15 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-37 Geneimmunoglobulin heavy variable 3-37 (pseudogene) |
IGHV3-36 Geneimmunoglobulin heavy variable 3-36 (pseudogene) |
IGHV3-35 Geneimmunoglobulin heavy variable 3-35 (non-functional) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-33 Geneimmunoglobulin heavy variable 3-33 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-32 Geneimmunoglobulin heavy variable 3-32 (pseudogene) |
IGHV3-30 Geneimmunoglobulin heavy variable 3-30 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Located in extracellular space. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-38 Geneimmunoglobulin heavy variable 3-38 (non-functional) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV3-1 GeneT cell receptor beta variable 3-1 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV7-9 GeneT cell receptor beta variable 7-9 Predicted to enable MHC protein binding activity and peptide antigen binding activity. Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV7-8 GeneT cell receptor beta variable 7-8 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV7-1 GeneT cell receptor beta variable 7-1 (non-functional) Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV7-3 GeneT cell receptor beta variable 7-3 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV7-2 GeneT cell receptor beta variable 7-2 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV7-5 GeneT cell receptor beta variable 7-5 (pseudogene) |
TRBV7-4 GeneT cell receptor beta variable 7-4 (gene/pseudogene) Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV7-7 GeneT cell receptor beta variable 7-7 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV7-6 GeneT cell receptor beta variable 7-6 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1-13 Geneimmunoglobulin kappa variable 1-13 (gene/pseudogene) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV3-7 Geneimmunoglobulin kappa variable 3-7 (non-functional) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV8-61 Geneimmunoglobulin lambda variable 8-61 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRAV5 GeneT cell receptor alpha variable 5 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
IGLV2-28 Geneimmunoglobulin lambda variable 2-28 (pseudogene) |
IGLV2-23 Geneimmunoglobulin lambda variable 2-23 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV1-12 Geneimmunoglobulin heavy variable 1-12 (pseudogene) |
IGHV1-14 Geneimmunoglobulin heavy variable 1-14 (pseudogene) |
IGHV3OR16-13 Geneimmunoglobulin heavy variable 3/OR16-13 (non-functional) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV7-34-1 Geneimmunoglobulin heavy variable 7-34-1 (pseudogene) |
IGHV3-30-2 Geneimmunoglobulin heavy variable 3-30-2 (pseudogene) |
IGHV3-30-3 Geneimmunoglobulin heavy variable 3-30-3 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-30-5 Geneimmunoglobulin heavy variable 3-30-5 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLVIV-53 Geneimmunoglobulin lambda variable (IV)-53 (pseudogene) |
IGLVIV-59 Geneimmunoglobulin lambda variable (IV)-59 (pseudogene) |
IGLVIVOR22-2 Geneimmunoglobulin lambda variable (IV)/OR22-2 (pseudogene) |
IGLVIVOR22-1 Geneimmunoglobulin lambda variable (IV)/OR22-1 (pseudogene) |
IGHV4-38-2 Geneimmunoglobulin heavy variable 4-38-2 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRGV5P GeneT cell receptor gamma variable 5P (pseudogene) |
IGKV2D-29 Geneimmunoglobulin kappa variable 2D-29 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV2D-28 Geneimmunoglobulin kappa variable 2D-28 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle and extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV2D-24 Geneimmunoglobulin kappa variable 2D-24 (non-functional) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV2D-26 Geneimmunoglobulin kappa variable 2D-26 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV2D-23 Geneimmunoglobulin kappa variable 2D-23 (pseudogene) |
IGKV1D-8 Geneimmunoglobulin kappa variable 1D-8 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV7-35 Geneimmunoglobulin lambda variable 7-35 (pseudogene) |
TRGV10 GeneT cell receptor gamma variable 10 (non-functional) Predicted to be involved in adaptive immune response. Predicted to be located in plasma membrane. Predicted to be part of T cell receptor complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHVII-49-1 Geneimmunoglobulin heavy variable (II)-49-1 (pseudogene) |
IGHV1OR15-2 Geneimmunoglobulin heavy variable 1/OR15-2 (pseudogene) |
IGHV1OR15-3 Geneimmunoglobulin heavy variable 1/OR15-3 (pseudogene) |
IGHV1OR15-1 Geneimmunoglobulin heavy variable 1/OR15-1 (non-functional) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV1OR15-6 Geneimmunoglobulin heavy variable 1/OR15-6 (pseudogene) |
IGHV1OR15-4 Geneimmunoglobulin heavy variable 1/OR15-4 (pseudogene) |
IGHV1OR15-9 Geneimmunoglobulin heavy variable 1/OR15-9 (non-functional) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV21OR9-2 GeneT cell receptor beta variable 21/OR9-2 (pseudogene) |
IGHVII-30-1 Geneimmunoglobulin heavy variable (II)-30-1 (pseudogene) |
IGHV2-70 Geneimmunoglobulin heavy variable 2-70 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1OR2-9 Geneimmunoglobulin kappa variable 1/OR2-9 (pseudogene) |
IGKV1D-22 Geneimmunoglobulin kappa variable 1D-22 (pseudogene) |
IGKV1D-27 Geneimmunoglobulin kappa variable 1D-27 (pseudogene) |
IGHV3-48 Geneimmunoglobulin heavy variable 3-48 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-49 Geneimmunoglobulin heavy variable 3-49 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-47 Geneimmunoglobulin heavy variable 3-47 (pseudogene) |
IGHV3-42 Geneimmunoglobulin heavy variable 3-42 (pseudogene) |
IGHV3-43 Geneimmunoglobulin heavy variable 3-43 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-41 Geneimmunoglobulin heavy variable 3-41 (pseudogene) |
IGLVI-56 Geneimmunoglobulin lambda variable (I)-56 (pseudogene) |
IGHVII-26-2 Geneimmunoglobulin heavy variable (II)-26-2 (pseudogene) |
IGKV2OR2-10 Geneimmunoglobulin kappa variable 2/OR2-10 (pseudogene) |
IGKV1ORY-1 Geneimmunoglobulin kappa variable 1/ORY-1 (pseudogene) |
IGHV3-43D Geneimmunoglobulin heavy variable 3-43D |
IGHVIII-44 Geneimmunoglobulin heavy variable (III)-44 (pseudogene) |
IGHV3-11 Geneimmunoglobulin heavy variable 3-11 (gene/pseudogene) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV10-54 Geneimmunoglobulin lambda variable 10-54 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHVII-31-1 Geneimmunoglobulin heavy variable (II)-31-1 (pseudogene) |
IGLV1-51 Geneimmunoglobulin lambda variable 1-51 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV1-50 Geneimmunoglobulin lambda variable 1-50 (non-functional) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV7-40 Geneimmunoglobulin heavy variable 7-40 (pseudogene) |
TRBV11-3 GeneT cell receptor beta variable 11-3 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV11-1 GeneT cell receptor beta variable 11-1 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
LOC100290036 Geneimmunglobulin heavy chain variable region |
TRAV20 GeneT cell receptor alpha variable 20 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRBV24-1 GeneT cell receptor beta variable 24-1 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV7-46 Geneimmunoglobulin lambda variable 7-46 (gene/pseudogene) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV7-43 Geneimmunoglobulin lambda variable 7-43 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHVII-44-2 Geneimmunoglobulin heavy variable (II)-44-2 (pseudogene) |
IGHVIII-2-1 Geneimmunoglobulin heavy variable (III)-2-1 (pseudogene) |
IGHVIII-16-1 Geneimmunoglobulin heavy variable (III)-16-1 (pseudogene) |
IGHV2-70D Geneimmunoglobulin heavy variable 2-70D Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV1-67 Geneimmunoglobulin heavy variable 1-67 (pseudogene) |
IGHV1-68 Geneimmunoglobulin heavy variable 1-68 (pseudogene) |
IGHV1-69 Geneimmunoglobulin heavy variable 1-69 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV4-39 Geneimmunoglobulin heavy variable 4-39 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV4-31 Geneimmunoglobulin heavy variable 4-31 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV10-2 GeneT cell receptor beta variable 10-2 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV10-3 GeneT cell receptor beta variable 10-3 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV10-1 GeneT cell receptor beta variable 10-1(gene/pseudogene) Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV2-26 Geneimmunoglobulin heavy variable 2-26 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1OR15-118 Geneimmunoglobulin kappa variable 1/OR15-118 (pseudogene) |
IGKV3D-7 Geneimmunoglobulin kappa variable 3D-7 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV25-1 GeneT cell receptor beta variable 25-1 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV6D-41 Geneimmunoglobulin kappa variable 6D-41 (non-functional) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV4OR15-8 Geneimmunoglobulin heavy variable 4/OR15-8 (non-functional) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV3-32 Geneimmunoglobulin lambda variable 3-32 (non-functional) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV3-31 Geneimmunoglobulin lambda variable 3-31 (pseudogene) |
IGLV3-30 Geneimmunoglobulin lambda variable 3-30 (pseudogene) |
TRBV17 GeneT cell receptor beta variable 17 (non-functional) Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV16 GeneT cell receptor beta variable 16 (gene/pseudogene) Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV15 GeneT cell receptor beta variable 15 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV14 GeneT cell receptor beta variable 14 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV13 GeneT cell receptor beta variable 13 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV19 GeneT cell receptor beta variable 19 Predicted to be involved in cell surface receptor signaling pathway. Part of alpha-beta T cell receptor complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV18 GeneT cell receptor beta variable 18 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRDV1 GeneT cell receptor delta variable 1 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRDV3 GeneT cell receptor delta variable 3 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRDV2 GeneT cell receptor delta variable 2 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
IGLV10-67 Geneimmunoglobulin lambda variable 10-67 (pseudogene) |
IGKV2-4 Geneimmunoglobulin kappa variable 2-4 (pseudogene) |
IGKV3-34 Geneimmunoglobulin kappa variable 3-34 (pseudogene) |
IGKV3-31 Geneimmunoglobulin kappa variable 3-31 (pseudogene) |
IGKV3OR2-5 Geneimmunoglobulin kappa variable 3/OR2-5 (pseudogene) |
TRBVAOR9-2 GeneT cell receptor beta variable A/OR9-2 (pseudogene) |
IGHV3-19 Geneimmunoglobulin heavy variable 3-19 (pseudogene) |
IGHV3-15 Geneimmunoglobulin heavy variable 3-15 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-16 Geneimmunoglobulin heavy variable 3-16 (non-functional) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-13 Geneimmunoglobulin heavy variable 3-13 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Located in blood microparticle. [provided by Alliance of Genome Resources, Mar 2025] |
IGLVI-20 Geneimmunoglobulin lambda variable (I)-20 (pseudogene) |
IGHVII-43-1 Geneimmunoglobulin heavy variable (II)-43-1 (pseudogene) |
IGHV4-55 Geneimmunoglobulin heavy variable 4-55 (pseudogene) |
LOC391405 Geneimmunoglobulin kappa light chain variable region |
IGKV1-27 Geneimmunoglobulin kappa variable 1-27 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1-22 Geneimmunoglobulin kappa variable 1-22 (pseudogene) |
IGHVIV-44-1 Geneimmunoglobulin heavy variable (IV)-44-1 (pseudogene) |
IGHV4-34 Geneimmunoglobulin heavy variable 4-34 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV2-23 Geneimmunoglobulin kappa variable 2-23 (pseudogene) |
IGKV2-26 Geneimmunoglobulin kappa variable 2-26 (pseudogene) |
IGKV2-28 Geneimmunoglobulin kappa variable 2-28 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV2-29 Geneimmunoglobulin kappa variable 2-29 (gene/pseudogene) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHVIII-47-1 Geneimmunoglobulin heavy variable (III)-47-1 (pseudogene) |
IGHVII-40-1 Geneimmunoglobulin heavy variable (II)-40-1 (pseudogene) |
TRBV6-4 GeneT cell receptor beta variable 6-4 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV6-1 GeneT cell receptor beta variable 6-1 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
IGLVVI-25-1 Geneimmunoglobulin lambda variable (VI)-25-1 (pseudogene) |
IGHV6-1 Geneimmunoglobulin heavy variable 6-1 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1OR-3 Geneimmunoglobulin kappa variable 1/OR-3 (pseudogene) |
IGKV1OR-2 Geneimmunoglobulin kappa variable 1/OR-2 (pseudogene) |
IGKV1OR-4 Geneimmunoglobulin kappa variable 1/OR-4 (pseudogene) |
IGLVVII-41-1 Geneimmunoglobulin lambda variable (VII)-41-1 (pseudogene) |
IGHVII-65-1 Geneimmunoglobulin heavy variable (II)-65-1 (pseudogene) |
IGKV2OR22-3 Geneimmunoglobulin kappa variable 2/OR22-3 (pseudogene) |
IGKV2OR22-4 Geneimmunoglobulin kappa variable 2/OR22-4 (pseudogene) |
IGHVII-53-1 Geneimmunoglobulin heavy variable (II)-53-1 (pseudogene) |
IGLV@ Geneimmunoglobulin lambda variable cluster Immunoglobulins (Ig) are the antigen recognition molecules of B cells. An Ig molecule is made up of 2 identical heavy chains (see MIM 147100) and 2 identical light chains, either kappa (see MIM 147200) or lambda, joined by disulfide bonds so that each heavy chain is linked to a light chain and the 2 heavy chains are linked together. The kappa and lambda light chains have no apparent functional differences. Each Ig lambda light chain has an N-terminal variable (V) region containing the antigen-binding site and a C-terminal constant (C) region, encoded by a C region gene (IGLC1; MIM 147220), that provides signaling functions. The lambda light chain V region is encoded by 2 types of genes: V genes and joining (J) genes (see MIM 147230). Random selection of just 1 gene of each type to assemble a V region accounts for the great diversity of V regions among Ig molecules. The lambda light chain locus on chromosome 22 contains approximately 30 functional V genes, followed by approximately 4 functional J genes. Due to polymorphism, the numbers of functional V and J genes differ among individuals (Janeway et al., 2005).[supplied by OMIM, Apr 2008] |
IGHV4-61 Geneimmunoglobulin heavy variable 4-61 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHVII-62-1 Geneimmunoglobulin heavy variable (II)-62-1 (pseudogene) |
IGHVII-20-1 Geneimmunoglobulin heavy variable (II)-20-1 (pseudogene) |
IGHVII-28-1 Geneimmunoglobulin heavy variable (II)-28-1 (pseudogene) |
IGLV5-37 Geneimmunoglobulin lambda variable 5-37 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV5-39 Geneimmunoglobulin lambda variable 5-39 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV28 GeneT cell receptor beta variable 28 Predicted to enable peptide antigen binding activity. Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV26 GeneT cell receptor beta variable 26 (pseudogene) |
IGHV3OR16-12 Geneimmunoglobulin heavy variable 3/OR16-12 (non-functional) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3OR16-11 Geneimmunoglobulin heavy variable 3/OR16-11 (pseudogene) |
IGHV3OR16-10 Geneimmunoglobulin heavy variable 3/OR16-10 (non-functional) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3OR16-16 Geneimmunoglobulin heavy variable 3/OR16-16 (pseudogene) |
IGHV3OR16-15 Geneimmunoglobulin heavy variable 3/OR16-15 (pseudogene) |
IGKV2-24 Geneimmunoglobulin kappa variable 2-24 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
BIVM Genebasic, immunoglobulin-like variable motif containing Located in extracellular space. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV4-60 Geneimmunoglobulin lambda variable 4-60 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV4-69 Geneimmunoglobulin lambda variable 4-69 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-25 Geneimmunoglobulin heavy variable 3-25 (pseudogene) |
IGHV3-20 Geneimmunoglobulin heavy variable 3-20 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-21 Geneimmunoglobulin heavy variable 3-21 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-22 Geneimmunoglobulin heavy variable 3-22 (pseudogene) |
IGHV3-23 Geneimmunoglobulin heavy variable 3-23 IGHV3-23 belongs to a cluster of approximately 40 functional variable (V) genes in the immunoglobulin (Ig) heavy chain locus on chromosome 14. For background information on the Ig heavy chain and the V gene cluster, see (MIM 147070).[supplied by OMIM, Apr 2008] |
IGLVI-70 Geneimmunoglobulin lambda variable (I)-70 (pseudogene) |
IGHV3-29 Geneimmunoglobulin heavy variable 3-29 (pseudogene) |
IGHV7-27 Geneimmunoglobulin heavy variable 7-27 (pseudogene) |
IGHV3OR15-7 Geneimmunoglobulin heavy variable 3/OR15-7 (pseudogene) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
LOC390714 Geneimmunoglobulin heavy chain variable region Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV3D-20 Geneimmunoglobulin kappa variable 3D-20 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV3D-25 Geneimmunoglobulin kappa variable 3D-25 (pseudogene) |
IGHVII-15-1 Geneimmunoglobulin heavy variable (II)-15-1 (pseudogene) |
IGLVVI-22-1 Geneimmunoglobulin lambda variable (VI)-22-1 (pseudogene) |
TRAV31 GeneT cell receptor alpha variable 31 (pseudogene) T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
VCX Genevariable charge, X-linked This gene belongs to the VCX/Y gene family, which has multiple members on both X and Y chromosomes, and all are expressed exclusively in male germ cells. The X-linked members are clustered on chromosome Xp22 and Y-linked members are two identical copies of the gene within a palindromic region on Yq11. The family members share a high degree of sequence identity, with the exception that a 30-bp unit is tandemly repeated in X-linked members but occurs only once in Y-linked members. The VCX gene cluster is polymorphic in terms of copy number; different individuals may have a different number of VCX genes. VCX/Y genes encode small and highly charged proteins of unknown function. The presence of a putative bipartite nuclear localization signal suggests that VCX/Y members are nuclear proteins. This gene contains 10 repeats of the 30-bp unit. [provided by RefSeq, Jul 2008] |
VCY Genevariable charge, Y-linked The protein encoded by this gene is a member of a family of human VCX/Y genes. This gene family has multiple members on both X and Y chromosomes, and all are expressed exclusively in male germ cells. Members of the VCX/Y family share a high degree of sequence identity, with the exception that a 30-bp unit is tandemly repeated in X-linked members but occurs only once in Y-linked members. VCX/Y genes encode small and highly charged proteins of unknown function. This gene encodes a small, positively charged protein. The presence of a putative bipartite nuclear localization signal suggests that this gene encodes a nuclear protein. The genome has two identical copies of this gene within a palindromic region; this record represents the more centromeric copy. [provided by RefSeq, Jul 2008] |
IGHVIII-25-1 Geneimmunoglobulin heavy variable (III)-25-1 (pseudogene) |
IGLV2-34 Geneimmunoglobulin lambda variable 2-34 (pseudogene) |
IGLV2-33 Geneimmunoglobulin lambda variable 2-33 (non-functional) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV20OR9-2 GeneT cell receptor beta variable 20/OR9-2 (non-functional) Predicted to be involved in cell surface receptor signaling pathway. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRAV2 GeneT cell receptor alpha variable 2 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV3 GeneT cell receptor alpha variable 3 (gene/pseudogene) T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV4 GeneT cell receptor alpha variable 4 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV6 GeneT cell receptor alpha variable 6 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV7 GeneT cell receptor alpha variable 7 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
IGHVIII-67-4 Geneimmunoglobulin heavy variable (III)-67-4 (pseudogene) |
IGHVIII-67-2 Geneimmunoglobulin heavy variable (III)-67-2 (pseudogene) |
IGHVIII-67-3 Geneimmunoglobulin heavy variable (III)-67-3 (pseudogene) |
IGKV1OR2-3 Geneimmunoglobulin kappa variable 1/OR2-3 (pseudogene) |
IGKV1OR2-0 Geneimmunoglobulin kappa variable 1/OR2-0 (non-functional) |
IGKV1OR2-1 Geneimmunoglobulin kappa variable 1/OR2-1 (pseudogene) |
IGKV1OR2-6 Geneimmunoglobulin kappa variable 1/OR2-6 (pseudogene) |
IGLV6-57 Geneimmunoglobulin lambda variable 6-57 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRAV22 GeneT cell receptor alpha variable 22 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV21 GeneT cell receptor alpha variable 21 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV27 GeneT cell receptor alpha variable 27 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV25 GeneT cell receptor alpha variable 25 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV24 GeneT cell receptor alpha variable 24 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV28 GeneT cell receptor alpha variable 28 (pseudogene) T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRBV25OR9-2 GeneT cell receptor beta variable 25/OR9-2 (pseudogene) |
IGHV3OR16-9 Geneimmunoglobulin heavy variable 3/OR16-9 (non-functional) Predicted to be involved in adaptive immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3OR16-8 Geneimmunoglobulin heavy variable 3/OR16-8 (non-functional) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV1OR15-5 Geneimmunoglobulin heavy variable 1/OR15-5 (non-functional) |
IGHV2-5 Geneimmunoglobulin heavy variable 2-5 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV4-59 Geneimmunoglobulin heavy variable 4-59 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1OR22-1 Geneimmunoglobulin kappa variable 1/OR22-1 (pseudogene) |
IGKV1OR22-5 Geneimmunoglobulin kappa variable 1/OR22-5 (pseudogene) |
IGKV6D-21 Geneimmunoglobulin kappa variable 6D-21 (non-functional) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-33-2 Geneimmunoglobulin heavy variable 3-33-2 (pseudogene) |
TRBV22OR9-2 GeneT cell receptor beta variable 22/OR9-2 (pseudogene) |
TRGV6 GeneT cell receptor gamma variable 6 (pseudogene) |
TRGV7 GeneT cell receptor gamma variable 7 (pseudogene) |
TRGV4 GeneT cell receptor gamma variable 4 Predicted to be involved in adaptive immune response and innate immune response. Predicted to be located in plasma membrane. Predicted to be part of T cell receptor complex. Predicted to be active in external side of plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRGV5 GeneT cell receptor gamma variable 5 Predicted to be involved in adaptive immune response and innate immune response. Predicted to be located in plasma membrane. Predicted to be part of T cell receptor complex. Predicted to be active in external side of plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRGV2 GeneT cell receptor gamma variable 2 Predicted to be involved in adaptive immune response and innate immune response. Predicted to be located in plasma membrane. Predicted to be part of T cell receptor complex. Predicted to be active in external side of plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRGV3 GeneT cell receptor gamma variable 3 Predicted to enable MHC protein binding activity and peptide antigen binding activity. Predicted to be involved in immune response. Predicted to be located in plasma membrane. Predicted to be part of T cell receptor complex. Predicted to be active in external side of plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRGV1 GeneT cell receptor gamma variable 1 (non-functional) Predicted to be involved in adaptive immune response. Predicted to be located in plasma membrane. Predicted to be part of T cell receptor complex. Predicted to be active in external side of plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRGV8 GeneT cell receptor gamma variable 8 Predicted to be involved in adaptive immune response and innate immune response. Predicted to be located in plasma membrane. Predicted to be part of T cell receptor complex. Predicted to be active in external side of plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRGV9 GeneT cell receptor gamma variable 9 Predicted to enable MHC protein binding activity and peptide antigen binding activity. Predicted to be involved in adaptive immune response and innate immune response. Predicted to be located in plasma membrane. Predicted to be part of T cell receptor complex. Predicted to be active in external side of plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRGVB GeneT cell receptor gamma variable B (pseudogene) |
TRGVA GeneT cell receptor gamma variable A (pseudogene) |
IGHVIII-22-2 Geneimmunoglobulin heavy variable (III)-22-2 (pseudogene) |
IGKV1D-39 Geneimmunoglobulin kappa variable 1D-39 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1D-33 Geneimmunoglobulin kappa variable 1D-33 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle and extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1D-32 Geneimmunoglobulin kappa variable 1D-32 (pseudogene) |
IGKV1D-35 Geneimmunoglobulin kappa variable 1D-35 (pseudogene) |
IGKV1D-37 Geneimmunoglobulin kappa variable 1D-37 (non-functional) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-79 Geneimmunoglobulin heavy variable 3-79 (pseudogene) |
IGHV3-73 Geneimmunoglobulin heavy variable 3-73 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-72 Geneimmunoglobulin heavy variable 3-72 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-71 Geneimmunoglobulin heavy variable 3-71 (pseudogene) |
IGHV3-76 Geneimmunoglobulin heavy variable 3-76 (pseudogene) |
IGHV3-75 Geneimmunoglobulin heavy variable 3-75 (pseudogene) |
IGHV3-74 Geneimmunoglobulin heavy variable 3-74 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLVI-42 Geneimmunoglobulin lambda variable (I)-42 (pseudogene) |
IGLV8OR8-1 Geneimmunoglobulin lambda variable 8/OR8-1 (pseudogene) |
IGKV1OR2-108 Geneimmunoglobulin kappa variable 1/OR2-108 (non-functional) Predicted to be involved in immune response. Predicted to be located in extracellular region. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3OR16-14 Geneimmunoglobulin heavy variable 3/OR16-14 (pseudogene) |
IGHV3OR16-6 Geneimmunoglobulin heavy variable 3/OR16-6 (pseudogene) |
TRAV26-1 GeneT cell receptor alpha variable 26-1 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV26-2 GeneT cell receptor alpha variable 26-2 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
IGHV3-7 Geneimmunoglobulin heavy variable 3-7 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Located in blood microparticle and extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-6 Geneimmunoglobulin heavy variable 3-6 (pseudogene) |
IGHV3-9 Geneimmunoglobulin heavy variable 3-9 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Located in extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV22-1 GeneT cell receptor beta variable 22-1 (pseudogene) |
IGHVIII-51-1 Geneimmunoglobulin heavy variable (III)-51-1 (pseudogene) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV1-46 Geneimmunoglobulin heavy variable 1-46 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRAV9-1 GeneT cell receptor alpha variable 9-1 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV9-2 GeneT cell receptor alpha variable 9-2 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
IGLV3-10 Geneimmunoglobulin lambda variable 3-10 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV3-13 Geneimmunoglobulin lambda variable 3-13 (pseudogene) |
IGLV3-12 Geneimmunoglobulin lambda variable 3-12 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV3-15 Geneimmunoglobulin lambda variable 3-15 (pseudogene) |
IGLV3-17 Geneimmunoglobulin lambda variable 3-17 (pseudogene) |
IGLV3-16 Geneimmunoglobulin lambda variable 3-16 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV3-19 Geneimmunoglobulin lambda variable 3-19 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1OR2-11 Geneimmunoglobulin kappa variable 1/OR2-11 (pseudogene) |
IGKV3D-11 Geneimmunoglobulin kappa variable 3D-11 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV3D-15 Geneimmunoglobulin kappa variable 3D-15 (gene/pseudogene) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV1-41 Geneimmunoglobulin lambda variable 1-41 (pseudogene) |
IGLV1-44 Geneimmunoglobulin lambda variable 1-44 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV1-47 Geneimmunoglobulin lambda variable 1-47 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV11-2 GeneT cell receptor beta variable 11-2 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV2-40 Geneimmunoglobulin kappa variable 2-40 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV7-4-1 Geneimmunoglobulin heavy variable 7-4-1 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1-5 Geneimmunoglobulin kappa variable 1-5 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle and extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV4-2 GeneT cell receptor beta variable 4-2 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV4-3 GeneT cell receptor beta variable 4-3 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV4-1 GeneT cell receptor beta variable 4-1 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV2OR2-2 Geneimmunoglobulin kappa variable 2/OR2-2 (pseudogene) |
IGKV2OR2-1 Geneimmunoglobulin kappa variable 2/OR2-1 (pseudogene) |
IGKV2OR2-7 Geneimmunoglobulin kappa variable 2/OR2-7 (pseudogene) |
IGKV2OR2-4 Geneimmunoglobulin kappa variable 2/OR2-4 (pseudogene) |
TRAV18 GeneT cell receptor alpha variable 18 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV19 GeneT cell receptor alpha variable 19 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV10 GeneT cell receptor alpha variable 10 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV11 GeneT cell receptor alpha variable 11 (pseudogene) T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV16 GeneT cell receptor alpha variable 16 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV17 GeneT cell receptor alpha variable 17 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV15 GeneT cell receptor alpha variable 15 (pseudogene) T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV8-1 GeneT cell receptor alpha variable 8-1 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV8-3 GeneT cell receptor alpha variable 8-3 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV8-2 GeneT cell receptor alpha variable 8-2 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV8-5 GeneT cell receptor alpha variable 8-5 (pseudogene) T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV8-4 GeneT cell receptor alpha variable 8-4 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV8-7 GeneT cell receptor alpha variable 8-7 (non-functional) T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV8-6 GeneT cell receptor alpha variable 8-6 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
IGHV1OR16-1 Geneimmunoglobulin heavy variable 1/OR16-1 (pseudogene) |
IGHV1OR16-3 Geneimmunoglobulin heavy variable 1/OR16-3 (pseudogene) |
IGHV1OR16-2 Geneimmunoglobulin heavy variable 1/OR16-2 (pseudogene) |
IGHV1OR16-4 Geneimmunoglobulin heavy variable 1/OR16-4 (pseudogene) |
TRBV5-7 GeneT cell receptor beta variable 5-7 (non-functional) Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV5-6 GeneT cell receptor beta variable 5-6 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV5-5 GeneT cell receptor beta variable 5-5 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV5-4 GeneT cell receptor beta variable 5-4 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV5-3 GeneT cell receptor beta variable 5-3 (non-functional) Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV5-2 GeneT cell receptor beta variable 5-2 (pseudogene) |
TRBV5-1 GeneT cell receptor beta variable 5-1 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV5-8 GeneT cell receptor beta variable 5-8 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV6-21 Geneimmunoglobulin kappa variable 6-21 (non-functional) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV1-58 Geneimmunoglobulin heavy variable 1-58 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHVIII-76-1 Geneimmunoglobulin heavy variable (III)-76-1 (pseudogene) |
IGHV2OR16-5 Geneimmunoglobulin heavy variable 2/OR16-5 (non-functional) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1OR9-1 Geneimmunoglobulin kappa variable 1/OR9-1 (pseudogene) |
TRBV8-2 GeneT cell receptor beta variable 8-2 (pseudogene) |
TRBV8-1 GeneT cell receptor beta variable 8-1 (pseudogene) |
IGHV4-80 Geneimmunoglobulin heavy variable 4-80 (pseudogene) |
IGHV7-81 Geneimmunoglobulin heavy variable 7-81 (non-functional) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV26OR9-2 GeneT cell receptor beta variable 26/OR9-2 (pseudogene) |
VCY1B Genevariable charge, Y-linked 1B The protein encoded by this gene is a member of a family of human VCX/Y genes. This gene family has multiple members on both X and Y chromosomes, and all are expressed exclusively in male germ cells. Members of the VCX/Y family share a high degree of sequence identity, with the exception that a 30-bp unit is tandemly repeated in X-linked members but occurs only once in Y-linked members. VCX/Y genes encode small and highly charged proteins of unknown function. This gene encodes a small, positively charged protein. The presence of a putative bipartite nuclear localization signal suggests that this gene encodes a nuclear protein. The genome has two identical copies of this gene within a palindromic region; this record represents the more telomeric copy. [provided by RefSeq, Jul 2008] |
IGHV1-24 Geneimmunoglobulin heavy variable 1-24 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV3-29 Geneimmunoglobulin lambda variable 3-29 (pseudogene) |
IGLV3-21 Geneimmunoglobulin lambda variable 3-21 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle and extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV3-22 Geneimmunoglobulin lambda variable 3-22 (gene/pseudogene) Predicted to be involved in immune response. Predicted to act upstream of or within apoptotic signaling pathway; negative regulation of stem cell proliferation; and regulation of G1/S transition of mitotic cell cycle. Predicted to be located in cytoplasm and extracellular space. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV3-24 Geneimmunoglobulin lambda variable 3-24 (pseudogene) |
IGLV3-25 Geneimmunoglobulin lambda variable 3-25 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV3-26 Geneimmunoglobulin lambda variable 3-26 (pseudogene) |
IGLV3-27 Geneimmunoglobulin lambda variable 3-27 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV5-52 Geneimmunoglobulin lambda variable 5-52 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
VCX2 Genevariable charge, X-linked 2 This gene belongs to the VCX/Y gene family, which has multiple members on both X and Y chromosomes that are expressed exclusively in male germ cells. The VCX gene cluster is polymorphic in terms of copy number; different individuals may have a different number of VCX genes. This gene contains two copies of a 30 nt tandem repeat. Deletion of a nearby member of this family was implicated in cognitive disability. [provided by RefSeq, Feb 2015] |
IGHVII-78-1 Geneimmunoglobulin heavy variable (II)-78-1 (pseudogene) |
IGHV1OR21-1 Geneimmunoglobulin heavy variable 1/OR21-1 (non-functional) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1-35 Geneimmunoglobulin kappa variable 1-35 (pseudogene) |
IGKV1-37 Geneimmunoglobulin kappa variable 1-37 (non-functional) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1-32 Geneimmunoglobulin kappa variable 1-32 (pseudogene) |
IGKV1-33 Geneimmunoglobulin kappa variable 1-33 Enables identical protein binding activity. Predicted to be involved in immune response. Located in blood microparticle. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1-39 Geneimmunoglobulin kappa variable 1-39 (gene/pseudogene) Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle and extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV23-1 GeneT cell receptor beta variable 23-1 (non-functional) Predicted to be involved in cell surface receptor signaling pathway. Predicted to be located in immunological synapse. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
FPEVF GeneEpilepsy, partial, with variable foci |
IGHVIII-5-2 Geneimmunoglobulin heavy variable (III)-5-2 (pseudogene) |
IGHVIII-5-1 Geneimmunoglobulin heavy variable (III)-5-1 (pseudogene) |
IGHV5-51 Geneimmunoglobulin heavy variable 5-51 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRAV41 GeneT cell receptor alpha variable 41 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV40 GeneT cell receptor alpha variable 40 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
IGLV2-11 Geneimmunoglobulin lambda variable 2-11 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV2-14 Geneimmunoglobulin lambda variable 2-14 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV2-18 Geneimmunoglobulin lambda variable 2-18 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1-6 Geneimmunoglobulin kappa variable 1-6 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1-8 Geneimmunoglobulin kappa variable 1-8 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1-9 Geneimmunoglobulin kappa variable 1-9 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
DEFA1A3 Genedefensin, alpha 1 and alpha 3, variable copy number locus |
IGHV3-64D Geneimmunoglobulin heavy variable 3-64D Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-38-3 Geneimmunoglobulin heavy variable 3-38-3 (non-functional) Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV4-30-4 Geneimmunoglobulin heavy variable 4-30-4 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV4-30-2 Geneimmunoglobulin heavy variable 4-30-2 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV4-30-1 Geneimmunoglobulin heavy variable 4-30-1 |
IGKV2-19 Geneimmunoglobulin kappa variable 2-19 (pseudogene) |
IGKV2-18 Geneimmunoglobulin kappa variable 2-18 (pseudogene) |
IGKV2-14 Geneimmunoglobulin kappa variable 2-14 (pseudogene) |
IGKV2-10 Geneimmunoglobulin kappa variable 2-10 (pseudogene) |
IGHVIII-38-1 Geneimmunoglobulin heavy variable (III)-38-1 (pseudogene) |
TRAV1-1 GeneT cell receptor alpha variable 1-1 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV1-2 GeneT cell receptor alpha variable 1-2 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
IGHVIII-82 Geneimmunoglobulin heavy variable (III)-82 (pseudogene) |
IGLV11-55 Geneimmunoglobulin lambda variable 11-55 (non-functional) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLVIV-65 Geneimmunoglobulin lambda variable (IV)-65 (pseudogene) |
IGLVIV-64 Geneimmunoglobulin lambda variable (IV)-64 (pseudogene) |
IGLV1-40 Geneimmunoglobulin lambda variable 1-40 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHVII-33-1 Geneimmunoglobulin heavy variable (II)-33-1 (pseudogene) |
IGKV2D-38 Geneimmunoglobulin kappa variable 2D-38 (pseudogene) |
IGKV2D-36 Geneimmunoglobulin kappa variable 2D-36 (pseudogene) |
IGKV2D-30 Geneimmunoglobulin kappa variable 2D-30 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV5-10-1 Geneimmunoglobulin heavy variable 5-10-1 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV2OR2-7D Geneimmunoglobulin kappa variable 2/OR2-7D (pseudogene) |
IGLV9-49 Geneimmunoglobulin lambda variable 9-49 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV2-8 Geneimmunoglobulin lambda variable 2-8 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV2-5 Geneimmunoglobulin lambda variable 2-5 (pseudogene) |
IGKV3OR2-268 Geneimmunoglobulin kappa variable 3/OR2-268 (non-functional) Predicted to be involved in immune response. Predicted to be located in extracellular region. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHVIII-11-1 Geneimmunoglobulin heavy variable (III)-11-1 (pseudogene) |
IGHVIII-13-1 Geneimmunoglobulin heavy variable (III)-13-1 (pseudogene) |
IGHVII-46-1 Geneimmunoglobulin heavy variable (II)-46-1 (pseudogene) |
TRBV27 GeneT cell receptor beta variable 27 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRAV38-1 GeneT cell receptor alpha variable 38-1 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
IGHVII-1-1 Geneimmunoglobulin heavy variable (II)-1-1 (pseudogene) |
IGKV1D-17 Geneimmunoglobulin kappa variable 1D-17 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1D-16 Geneimmunoglobulin kappa variable 1D-16 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1D-13 Geneimmunoglobulin kappa variable 1D-13 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1D-12 Geneimmunoglobulin kappa variable 1D-12 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle and extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV3-2 GeneT cell receptor beta variable 3-2 (pseudogene) |
IGLVV-66 Geneimmunoglobulin lambda variable (V)-66 (pseudogene) |
IGHV3-50 Geneimmunoglobulin heavy variable 3-50 (pseudogene) |
IGHV3-53 Geneimmunoglobulin heavy variable 3-53 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-52 Geneimmunoglobulin heavy variable 3-52 (pseudogene) |
IGHV3-54 Geneimmunoglobulin heavy variable 3-54 (pseudogene) |
IGHV3-57 Geneimmunoglobulin heavy variable 3-57 (pseudogene) |
IGLVI-63 Geneimmunoglobulin lambda variable (I)-63 (pseudogene) |
IGLVI-68 Geneimmunoglobulin lambda variable (I)-68 (pseudogene) |
IGHVII-67-1 Geneimmunoglobulin heavy variable (II)-67-1 (pseudogene) |
IGKV@ Geneimmunoglobulin kappa variable cluster Immunoglobulins (Ig) are the antigen recognition molecules of B cells. An Ig molecule is made up of 2 identical heavy chains (see MIM 147100) and 2 identical light chains, either kappa or lambda (see MIM 147220), joined by disulfide bonds so that each heavy chain is linked to a light chain and the 2 heavy chains are linked together. The kappa and lambda light chains have no apparent functional differences. Each Ig kappa light chain has an N-terminal variable (V) region containing the antigen-binding site and a C-terminal constant (C) region, encoded by a C region gene (IGKC; MIM 147200), that provides signaling functions. The kappa light chain V region is encoded by 2 types of genes: V genes and joining (J) genes (see MIM 146970). Random selection of just 1 gene of each type to assemble a V region accounts for the great diversity of V regions among Ig molecules. The kappa light chain locus on chromosome 2 contains approximately 40 functional V genes, followed by approximately 5 functional J genes. Due to polymorphism, the numbers of functional V and J genes differ among individuals (Janeway et al., 2005).[supplied by OMIM, Apr 2008] |
TRBV12-4 GeneT cell receptor beta variable 12-4 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV12-5 GeneT cell receptor beta variable 12-5 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV12-1 GeneT cell receptor beta variable 12-1 (pseudogene) |
TRBV12-2 GeneT cell receptor beta variable 12-2 (pseudogene) Predicted to be involved in immune system process. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV12-3 GeneT cell receptor beta variable 12-3 Predicted to enable MHC protein binding activity and peptide antigen binding activity. Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV3-4 Geneimmunoglobulin lambda variable 3-4 (pseudogene) |
IGLV3-7 Geneimmunoglobulin lambda variable 3-7 (pseudogene) |
IGLV3-6 Geneimmunoglobulin lambda variable 3-6 (pseudogene) |
IGLV3-1 Geneimmunoglobulin lambda variable 3-1 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV3-2 Geneimmunoglobulin lambda variable 3-2 (pseudogene) |
IGLV3-9 Geneimmunoglobulin lambda variable 3-9 (gene/pseudogene) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHVII-74-1 Geneimmunoglobulin heavy variable (II)-74-1 (pseudogene) |
IGKV3D-34 Geneimmunoglobulin kappa variable 3D-34 (pseudogene) |
IGKV3D-31 Geneimmunoglobulin kappa variable 3D-31 (pseudogene) |
VCX3B Genevariable charge, X-linked 3B This gene belongs to the VCX/Y gene family, which has multiple members on both X and Y chromosomes, and all are expressed exclusively in male germ cells. The X-linked members are clustered on chromosome Xp22, and the Y-linked members are two identical copies of the gene within a palindromic region on chromosome Yq11. The family members share a high degree of sequence identity, with the exception that a 30-nt unit is tandemly repeated in X-linked members but occurs only once in Y-linked members. The VCX gene cluster is polymorphic in terms of copy number; different individuals may have a different number of VCX genes. This family member, as represented by the reference genome allele, contains 14 copies of the 30-nt repeat unit. VCX/Y genes encode small and highly charged proteins containing putative bipartite nuclear localization signals. Although the exact function of this family member has yet to be determined, a role in mRNA stability regulation can be inferred from the ability of the highly similar family member, VCX-A, to inhibit mRNA decapping. A possible role in the regulation of ribosome assembly during spermatogenesis has also been suggested. [provided by RefSeq, Aug 2010] |
VCX3A Genevariable charge, X-linked 3A This gene belongs to the VCX/Y gene family, which has multiple members on both X and Y chromosomes, and all are expressed exclusively in male germ cells. The X-linked members are clustered on chromosome Xp22 and Y-linked members are two identical copies of the gene within a palindromic region on Yq11. The family members share a high degree of sequence identity, with the exception that a 30-bp unit is tandemly repeated in X-linked members but occurs only once in Y-linked members. The VCX gene cluster is polymorphic in terms of copy number; different individuals may have a different number of VCX genes. VCX/Y genes encode small and highly charged proteins of unknown function. The presence of a putative bipartite nuclear localization signal suggests that VCX/Y members are nuclear proteins. This gene contains 8 repeats of the 30-bp unit. [provided by RefSeq, Jul 2008] |
IGKV3OR22-2 Geneimmunoglobulin kappa variable 3/OR22-2 (pseudogene) |
IGLV1-62 Geneimmunoglobulin lambda variable 1-62 (pseudogene) |
TRBV9 GeneT cell receptor beta variable 9 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV2 GeneT cell receptor beta variable 2 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV1 GeneT cell receptor beta variable 1 (pseudogene) |
IGHV7-56 Geneimmunoglobulin heavy variable 7-56 (pseudogene) |
TRBVC GeneT cell receptor beta variable C |
TRBVB GeneT cell receptor beta variable B (pseudogene) |
TRBVA GeneT cell receptor beta variable A (pseudogene) |
IGKV5-2 Geneimmunoglobulin kappa variable 5-2 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV7-3 Geneimmunoglobulin kappa variable 7-3 (pseudogene) |
TRAV34 GeneT cell receptor alpha variable 34 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV35 GeneT cell receptor alpha variable 35 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV37 GeneT cell receptor alpha variable 37 (pseudogene) T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV30 GeneT cell receptor alpha variable 30 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV32 GeneT cell receptor alpha variable 32 (pseudogene) T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV33 GeneT cell receptor alpha variable 33 (pseudogene) T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV39 GeneT cell receptor alpha variable 39 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
IGKV2D-40 Geneimmunoglobulin kappa variable 2D-40 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle and extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
IGLVIV-66-1 Geneimmunoglobulin lambda variable (IV)-66-1 (pseudogene) |
TRBV29OR9-2 GeneT cell receptor beta variable 29/OR9-2 (non-functional) |
IGHV4-28 Geneimmunoglobulin heavy variable 4-28 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV1-17 Geneimmunoglobulin heavy variable 1-17 (pseudogene) |
IGHV1-18 Geneimmunoglobulin heavy variable 1-18 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLVV-58 Geneimmunoglobulin lambda variable (V)-58 (pseudogene) |
TRBV24OR9-2 GeneT cell receptor beta variable 24/OR9-2 (pseudogene) |
IGKV1OR1-1 Geneimmunoglobulin kappa variable 1/OR1-1 (pseudogene) |
TRGV11 GeneT cell receptor gamma variable 11 (non-functional) Predicted to be involved in adaptive immune response. Predicted to be located in external side of plasma membrane. Predicted to be part of T cell receptor complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV4-1 Geneimmunoglobulin kappa variable 4-1 Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV1-69D Geneimmunoglobulin heavy variable 1-69D Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGLV4-3 Geneimmunoglobulin lambda variable 4-3 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRAV12-1 GeneT cell receptor alpha variable 12-1 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV12-3 GeneT cell receptor alpha variable 12-3 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV12-2 GeneT cell receptor alpha variable 12-2 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
IGHV2-10 Geneimmunoglobulin heavy variable 2-10 (pseudogene) |
TRAV13-1 GeneT cell receptor alpha variable 13-1 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
TRAV13-2 GeneT cell receptor alpha variable 13-2 T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016] |
IGHV3-60 Geneimmunoglobulin heavy variable 3-60 (pseudogene) |
IGHV3-62 Geneimmunoglobulin heavy variable 3-62 (pseudogene) |
IGHV3-63 Geneimmunoglobulin heavy variable 3-63 (pseudogene) |
IGHV3-64 Geneimmunoglobulin heavy variable 3-64 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGHV3-65 Geneimmunoglobulin heavy variable 3-65 (pseudogene) |
IGHV3-66 Geneimmunoglobulin heavy variable 3-66 Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
TRBV29-1 GeneT cell receptor beta variable 29-1 Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1OR2-118 Geneimmunoglobulin kappa variable 1/OR2-118 (pseudogene) |
IGHVII-51-2 Geneimmunoglobulin heavy variable (II)-51-2 (pseudogene) |
IGKV3-20 Geneimmunoglobulin kappa variable 3-20 Predicted to enable antigen binding activity. Involved in glomerular filtration. Located in extracellular space. Part of monomeric IgA immunoglobulin complex; pentameric IgM immunoglobulin complex; and secretory IgA immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV3-25 Geneimmunoglobulin kappa variable 3-25 (pseudogene) |
IGKV1D-42 Geneimmunoglobulin kappa variable 1D-42 (non-functional) Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
IGKV1D-43 Geneimmunoglobulin kappa variable 1D-43 Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025] |
immunodeficiency, common variable, 6 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency, common variable, 6 phenotype from the curated OMIM Gene-Disease Associations dataset. |
Common variable immunodeficiency 8, with autoimmunity Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Common variable immunodeficiency 8, with autoimmunity phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Common variable immunodeficiency 9 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Common variable immunodeficiency 9 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Common variable immunodeficiency 2 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Common variable immunodeficiency 2 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Common variable immunodeficiency 7 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Common variable immunodeficiency 7 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Common variable immunodeficiency 6 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Common variable immunodeficiency 6 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Common Variable Immunodeficiency Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Common Variable Immunodeficiency from the curated CTD Gene-Disease Associations dataset. |
common variable immunodeficiency Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores genes involed in the disease common variable immunodeficiency from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. |
common variable immunodeficiency Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores genes co-occuring with the disease common variable immunodeficiency in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. |
common variable immunodeficiency; igg deficiency Gene SetFrom GAD Gene-Disease Associations genes associated with the disease common variable immunodeficiency; igg deficiency in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
common variable immunodeficiency; hemochromatosis Gene SetFrom GAD Gene-Disease Associations genes associated with the disease common variable immunodeficiency; hemochromatosis in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
common variable immunodeficiency; lung diseases Gene SetFrom GAD Gene-Disease Associations genes associated with the disease common variable immunodeficiency; lung diseases in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
bronchiectasis; common variable immunodeficiency Gene SetFrom GAD Gene-Disease Associations genes associated with the disease bronchiectasis; common variable immunodeficiency in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
common variable immunodeficiency; crohn disease; crohn's disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease common variable immunodeficiency; crohn disease; crohn's disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
common variable immunodeficiency; lymphoproliferative disorders Gene SetFrom GAD Gene-Disease Associations genes associated with the disease common variable immunodeficiency; lymphoproliferative disorders in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
common variable immunodeficiency; respiratory tract infections Gene SetFrom GAD Gene-Disease Associations genes associated with the disease common variable immunodeficiency; respiratory tract infections in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
common variable immunodeficiency Gene SetFrom GAD Gene-Disease Associations genes associated with the disease common variable immunodeficiency in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
iga deficiency and common variable immunodeficiency Gene SetFrom GAD Gene-Disease Associations genes associated with the disease iga deficiency and common variable immunodeficiency in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
common variable immunodeficiency; cytomegalovirus infections; graft vs host disease; hematologic diseases; recurrence Gene SetFrom GAD Gene-Disease Associations genes associated with the disease common variable immunodeficiency; cytomegalovirus infections; graft vs host disease; hematologic diseases; recurrence in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
common variable immunodeficiency; Gene SetFrom GAD Gene-Disease Associations genes associated with the disease common variable immunodeficiency; in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
celiac disease; common variable immunodeficiency; iga deficiency Gene SetFrom GAD Gene-Disease Associations genes associated with the disease celiac disease; common variable immunodeficiency; iga deficiency in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
common variable immunodeficiency; hemochromatosis; igg deficiency; infection Gene SetFrom GAD Gene-Disease Associations genes associated with the disease common variable immunodeficiency; hemochromatosis; igg deficiency; infection in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
common variable immunodeficiency Gene SetFrom GWASdb SNP-Disease Associations genes associated with the disease common variable immunodeficiency in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. |
Common Variable Immunodeficiency Gene SetFrom HuGE Navigator Gene-Phenotype Associations genes associated with the Common Variable Immunodeficiency phenotype by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. |
immunodeficiency, common variable, 8, with autoimmunity Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency, common variable, 8, with autoimmunity phenotype from the curated OMIM Gene-Disease Associations dataset. |
?immunodeficiency, common variable, 11 Gene SetFrom OMIM Gene-Disease Associations genes associated with the ?immunodeficiency, common variable, 11 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency, common variable, 10 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency, common variable, 10 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency, common variable, 5 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency, common variable, 5 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency, common variable, 4 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency, common variable, 4 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency, common variable, 7 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency, common variable, 7 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency, common variable, 1 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency, common variable, 1 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency, common variable, 3 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency, common variable, 3 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency, common variable, 2 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency, common variable, 2 phenotype from the curated OMIM Gene-Disease Associations dataset. |
Common Variable Immunodeficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Common Variable Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Common variable immunodeficiency Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores 2025 genes involed in the disease Common variable immunodeficiency from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. |
Common variable immunodeficiency Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Common variable immunodeficiency in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Common variable immunodeficiency 8 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Common variable immunodeficiency 8 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Common variable immunodeficiency 2 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Common variable immunodeficiency 2 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Common variable immunodeficiency 1 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Common variable immunodeficiency 1 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Common variable immunodeficiency 3 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Common variable immunodeficiency 3 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Common variable immunodeficiency 12 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Common variable immunodeficiency 12 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Common variable immunodeficiency 7 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Common variable immunodeficiency 7 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Common variable immunodeficiency 5 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Common variable immunodeficiency 5 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Common variable immunodeficiency 6 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Common variable immunodeficiency 6 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Common variable immunodeficiency 10 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Common variable immunodeficiency 10 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Common variable immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Common variable immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Common Variable Immune Deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Common Variable Immune Deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency 18, severe combined immunodeficiency variant Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 18, severe combined immunodeficiency variant phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
acquired immunodeficiency syndrome; hiv infections; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome; hiv infections; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
acquired immunodeficiency syndrome; chromosome deletion; hiv infections; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome; chromosome deletion; hiv infections; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
acquired immunodeficiency syndrome; hiv infections; pregnancy complications, infectious; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome; hiv infections; pregnancy complications, infectious; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
acquired immunodeficiency syndrome; hiv infections; spondylarthropathies; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome; hiv infections; spondylarthropathies; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
Epilepsy, partial, with variable foci Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Epilepsy, partial, with variable foci phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Epilepsy, X-linked, with variable learning disabilities and behavior disorders Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Epilepsy, X-linked, with variable learning disabilities and behavior disorders phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders from the curated CTD Gene-Disease Associations dataset. |
Epilepsy, Partial, with Variable Foci Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Epilepsy, Partial, with Variable Foci from the curated CTD Gene-Disease Associations dataset. |
variable age at onset electroclinical syndrome Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores genes involed in the disease variable age at onset electroclinical syndrome from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. |
variable age at onset electroclinical syndrome Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores genes co-occuring with the disease variable age at onset electroclinical syndrome in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. |
variable myopathy Gene SetFrom GAD Gene-Disease Associations genes associated with the disease variable myopathy in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
variable age at onset disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease variable age at onset disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
variable Gene SetFrom GeneRIF Biological Term Annotations genes co-occuring with the biological term variable in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. |
variable expressivity Gene SetFrom HPO Gene-Disease Associations genes associated with the variable expressivity phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. |
variable body spotting Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the variable body spotting phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
variable depigmentation Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the variable depigmentation phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
epilepsy, familial focal, with variable foci Gene SetFrom OMIM Gene-Disease Associations genes associated with the epilepsy, familial focal, with variable foci phenotype from the curated OMIM Gene-Disease Associations dataset. |
epilepsy, x-linked, with variable learning disabilities and behavior disorders Gene SetFrom OMIM Gene-Disease Associations genes associated with the epilepsy, x-linked, with variable learning disabilities and behavior disorders phenotype from the curated OMIM Gene-Disease Associations dataset. |
conotruncal heart malformations, variable Gene SetFrom OMIM Gene-Disease Associations genes associated with the conotruncal heart malformations, variable phenotype from the curated OMIM Gene-Disease Associations dataset. |
Variable Expressivity Gene SetFrom DisGeNET Gene-Phenotype Associations genes associated with the phenotype Variable Expressivity in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset. |
variable body spotting Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the variable body spotting phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
variable depigmentation Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the variable depigmentation phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
Familial focal epilepsy with variable foci Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores 2025 genes involed in the disease Familial focal epilepsy with variable foci from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. |
Variable age at onset electroclinical syndrome Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores 2025 genes involed in the disease Variable age at onset electroclinical syndrome from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. |
Variable age at onset electroclinical syndrome Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Variable age at onset electroclinical syndrome in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Familial focal epilepsy with variable foci Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Familial focal epilepsy with variable foci in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
stress-induced childhood-onset neurodegeneration with variable ataxia and seizures Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease stress-induced childhood-onset neurodegeneration with variable ataxia and seizures in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Vertebral anomalies and variable endocrine and T-cell dysfunction Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Vertebral anomalies and variable endocrine and T-cell dysfunction in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Familial focal epilepsy with variable foci 1 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Familial focal epilepsy with variable foci 1 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Familial focal epilepsy with variable foci 3 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Familial focal epilepsy with variable foci 3 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
X-linked epilepsy with variable learning disabilities and behavior disorders Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease X-linked epilepsy with variable learning disabilities and behavior disorders in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Vertebral anomalies and variable endocrine and T-cell dysfunction Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Vertebral anomalies and variable endocrine and T-cell dysfunction phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
PMC7479515-mmc4.xlsx-ST-RELA-variable-Unnamed_6_RELA Gene SetFrom Rummagene Transcription Factor Associations 2026 target genes of the PMC7479515-mmc4.xlsx-ST-RELA-variable-Unnamed_6_RELA transcription factor from the Rummagene Transcription Factor Associations 2026 dataset. |
PMC7479515-mmc8.xlsx-ST-RELA-variable-Unnamed_1_RELA Gene SetFrom Rummagene Transcription Factor Associations 2026 target genes of the PMC7479515-mmc8.xlsx-ST-RELA-variable-Unnamed_1_RELA transcription factor from the Rummagene Transcription Factor Associations 2026 dataset. |
PMC7479515-mmc8.xlsx-ST-RELA-variable-Unnamed_6_RELA Gene SetFrom Rummagene Transcription Factor Associations 2026 target genes of the PMC7479515-mmc8.xlsx-ST-RELA-variable-Unnamed_6_RELA transcription factor from the Rummagene Transcription Factor Associations 2026 dataset. |
PMC7479515-mmc8.xlsx-ST-RELA-variable-Unnamed_11_RELA Gene SetFrom Rummagene Transcription Factor Associations 2026 target genes of the PMC7479515-mmc8.xlsx-ST-RELA-variable-Unnamed_11_RELA transcription factor from the Rummagene Transcription Factor Associations 2026 dataset. |
PMC7479515-mmc8.xlsx-ST-RELA-variable-Unnamed_15_RELA Gene SetFrom Rummagene Transcription Factor Associations 2026 target genes of the PMC7479515-mmc8.xlsx-ST-RELA-variable-Unnamed_15_RELA transcription factor from the Rummagene Transcription Factor Associations 2026 dataset. |
PMC7479515-mmc8.xlsx-ST-RELA-variable-Unnamed_17_RELA Gene SetFrom Rummagene Transcription Factor Associations 2026 target genes of the PMC7479515-mmc8.xlsx-ST-RELA-variable-Unnamed_17_RELA transcription factor from the Rummagene Transcription Factor Associations 2026 dataset. |
PMC7479515-mmc8.xlsx-ST-RELA-variable-Unnamed_20_RELA Gene SetFrom Rummagene Transcription Factor Associations 2026 target genes of the PMC7479515-mmc8.xlsx-ST-RELA-variable-Unnamed_20_RELA transcription factor from the Rummagene Transcription Factor Associations 2026 dataset. |
Common Cold Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Common Cold from the curated CTD Gene-Disease Associations dataset. |
common bile duct disease Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores genes co-occuring with the disease common bile duct disease in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. |
common wart Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores genes co-occuring with the disease common wart in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. |
common cold Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores genes co-occuring with the disease common cold in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. |
common cold; otitis media; picornaviridae infections Gene SetFrom GAD Gene-Disease Associations genes associated with the disease common cold; otitis media; picornaviridae infections in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
common cold; Gene SetFrom GAD Gene-Disease Associations genes associated with the disease common cold; in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
allergies; common cold Gene SetFrom GAD Gene-Disease Associations genes associated with the disease allergies; common cold in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
adenoma; carcinoma; common bile duct neoplasms Gene SetFrom GAD Gene-Disease Associations genes associated with the disease adenoma; carcinoma; common bile duct neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
adenocarcinoma; carcinoma, pancreatic ductal; common bile duct neoplasms; pancreatic neoplasms Gene SetFrom GAD Gene-Disease Associations genes associated with the disease adenocarcinoma; carcinoma, pancreatic ductal; common bile duct neoplasms; pancreatic neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
common Gene SetFrom GeneRIF Biological Term Annotations genes co-occuring with the biological term common in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. |
common bile duct development Gene SetFrom GO Biological Process Annotations 2015 genes participating in the common bile duct development biological process from the curated GO Biological Process Annotations 2015 dataset. |
common-partner smad protein phosphorylation Gene SetFrom GO Biological Process Annotations 2015 genes participating in the common-partner smad protein phosphorylation biological process from the curated GO Biological Process Annotations 2015 dataset. |
blood coagulation, common pathway Gene SetFrom GO Biological Process Annotations 2015 genes participating in the blood coagulation, common pathway biological process from the curated GO Biological Process Annotations 2015 dataset. |
common myeloid progenitor cell proliferation Gene SetFrom GO Biological Process Annotations 2015 genes participating in the common myeloid progenitor cell proliferation biological process from the curated GO Biological Process Annotations 2015 dataset. |
transforming growth factor beta receptor, common-partner cytoplasmic mediator activity Gene SetFrom GO Molecular Function Annotations 2015 genes performing the transforming growth factor beta receptor, common-partner cytoplasmic mediator activity molecular function from the curated GO Molecular Function Annotations 2015 dataset. |
Common traits (Other) Gene SetFrom GWAS Catalog SNP-Phenotype Associations genes associated with the Common traits (Other) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. |
abnormality of the common coagulation pathway Gene SetFrom GWASdb SNP-Phenotype Associations genes associated with the abnormality of the common coagulation pathway phenotype in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. |
abnormality of the common coagulation pathway Gene SetFrom HPO Gene-Disease Associations genes associated with the abnormality of the common coagulation pathway phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. |
common atrium Gene SetFrom HPO Gene-Disease Associations genes associated with the common atrium phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. |
Common Bile Duct Neoplasms Gene SetFrom HuGE Navigator Gene-Phenotype Associations genes associated with the Common Bile Duct Neoplasms phenotype by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. |
Common Cold Gene SetFrom HuGE Navigator Gene-Phenotype Associations genes associated with the Common Cold phenotype by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. |
Cytokine IL-3/IL-5/GM-CSF receptor common beta chain Gene SetFrom InterPro Predicted Protein Domain Annotations proteins predicted to have the Cytokine IL-3/IL-5/GM-CSF receptor common beta chain protein domain from the InterPro Predicted Protein Domain Annotations dataset. |
abnormal common myeloid progenitor cell morphology Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the abnormal common myeloid progenitor cell morphology phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
decreased common myeloid progenitor cell number Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the decreased common myeloid progenitor cell number phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
unbalanced complete common atrioventricular canal Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the unbalanced complete common atrioventricular canal phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
abnormal common lymphocyte progenitor cell morphology Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the abnormal common lymphocyte progenitor cell morphology phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
common atrioventricular valve Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the common atrioventricular valve phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
common truncal valve Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the common truncal valve phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
common ventricle Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the common ventricle phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
abnormal common cardinal vein morphology Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the abnormal common cardinal vein morphology phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
common atrium Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the common atrium phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
abnormal common carotid artery morphology Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the abnormal common carotid artery morphology phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
abnormal common crus morphology Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the abnormal common crus morphology phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
abnormal common bile duct morphology Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the abnormal common bile duct morphology phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
absent common crus Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the absent common crus phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
absent common myeloid progenitor cells Gene SetFrom MPO Gene-Phenotype Associations gene mutations causing the absent common myeloid progenitor cells phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset. |
Common Pathway Gene Setproteins participating in the Common Pathway pathway from the Reactome Pathways dataset. |
common cardinal vein Gene SetFrom TISSUES Text-mining Tissue Protein Expression Evidence Scores proteins co-occuring with the tissue common cardinal vein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. |
common penile artery Gene SetFrom TISSUES Text-mining Tissue Protein Expression Evidence Scores proteins co-occuring with the tissue common penile artery in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. |
Common Cold Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Common Cold in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Common Acute Lymphoblastic Leukemia Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Common Acute Lymphoblastic Leukemia in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Common Migraine Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Common Migraine in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Arterial Diseases, Common Carotid Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Arterial Diseases, Common Carotid in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Common Wart Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Common Wart in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Common Carotid Artery Stenosis Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Common Carotid Artery Stenosis in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Common Ventricle Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Common Ventricle in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Common Atrium Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Common Atrium in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Common Atrioventricular Canal Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Common Atrioventricular Canal in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Common Carotid Artery Thrombosis Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Common Carotid Artery Thrombosis in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Common Bile Duct Calculi Gene SetFrom DisGeNET Gene-Phenotype Associations genes associated with the phenotype Common Bile Duct Calculi in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset. |
Cutaneous Leiomyosarcoma (Less Common) Gene SetFrom DisGeNET Gene-Phenotype Associations genes associated with the phenotype Cutaneous Leiomyosarcoma (Less Common) in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset. |
Uterine Leiomyosarcoma (Less Common) Gene SetFrom DisGeNET Gene-Phenotype Associations genes associated with the phenotype Uterine Leiomyosarcoma (Less Common) in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset. |
Abnormal Common Carotid Artery Morphology Gene SetFrom DisGeNET Gene-Phenotype Associations genes associated with the phenotype Abnormal Common Carotid Artery Morphology in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset. |
common-partner SMAD protein phosphorylation Gene SetFrom GO Biological Process Annotations 2023 genes participating in the common-partner SMAD protein phosphorylation biological process from the curated GO Biological Process Annotations 2023 dataset. |
blood coagulation, common pathway Gene SetFrom GO Biological Process Annotations 2023 genes participating in the blood coagulation, common pathway biological process from the curated GO Biological Process Annotations 2023 dataset. |
abnormal common cardinal vein morphology Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the abnormal common cardinal vein morphology phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
common atrium Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the common atrium phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
common atrioventricular valve Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the common atrioventricular valve phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
absent common myeloid progenitor cells Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the absent common myeloid progenitor cells phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
absent common crus Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the absent common crus phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
common ventricle Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the common ventricle phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
abnormal common myeloid progenitor cell morphology Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the abnormal common myeloid progenitor cell morphology phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
decreased common myeloid progenitor cell number Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the decreased common myeloid progenitor cell number phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
abnormal common crus morphology Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the abnormal common crus morphology phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
abnormal common lymphocyte progenitor cell morphology Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the abnormal common lymphocyte progenitor cell morphology phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
abnormal common carotid artery morphology Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the abnormal common carotid artery morphology phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
common truncal valve Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the common truncal valve phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
abnormal common bile duct morphology Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the abnormal common bile duct morphology phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
unbalanced complete common atrioventricular canal Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the unbalanced complete common atrioventricular canal phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
anastomosis between common carotid and vertebral artery Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the anastomosis between common carotid and vertebral artery phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
increased common myeloid progenitor cell number Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the increased common myeloid progenitor cell number phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
decreased common lymphocyte progenitor cell number Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the decreased common lymphocyte progenitor cell number phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
increased common lymphocyte progenitor cell number Gene SetFrom MGI Mouse Phenotype Associations 2023 gene mutations causing the increased common lymphocyte progenitor cell number phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset. |
Human - Bone Marrow - L2 - Common Lymphoid Progenitor Gene SetFrom HuBMAP Azimuth Cell Type Annotations genes associated with the Human - Bone Marrow - L2 - Common Lymphoid Progenitor cell type from the HuBMAP Azimuth Cell Type Annotations dataset. |
Common myeloid progenitor cell_Bone marrow_Human Gene SetFrom CellMarker Gene-Cell Type Associations genes associated with the Common myeloid progenitor cell_Bone marrow_Human cell type from the CellMarker Gene-Cell Type Associations dataset. |
Common lymphoid progenitor cell_Bone marrow_Human Gene SetFrom CellMarker Gene-Cell Type Associations genes associated with the Common lymphoid progenitor cell_Bone marrow_Human cell type from the CellMarker Gene-Cell Type Associations dataset. |
CD34+ common lymphoid progenitor cell_Bone marrow_Human Gene SetFrom CellMarker Gene-Cell Type Associations genes associated with the CD34+ common lymphoid progenitor cell_Bone marrow_Human cell type from the CellMarker Gene-Cell Type Associations dataset. |
Common lymphoid progenitor cell_Germ_Human Gene SetFrom CellMarker Gene-Cell Type Associations genes associated with the Common lymphoid progenitor cell_Germ_Human cell type from the CellMarker Gene-Cell Type Associations dataset. |
Common myeloid progenitor cell_Undefined_Human Gene SetFrom CellMarker Gene-Cell Type Associations genes associated with the Common myeloid progenitor cell_Undefined_Human cell type from the CellMarker Gene-Cell Type Associations dataset. |
Common lymphoid progenitor cell_Undefined_Human Gene SetFrom CellMarker Gene-Cell Type Associations genes associated with the Common lymphoid progenitor cell_Undefined_Human cell type from the CellMarker Gene-Cell Type Associations dataset. |
Common myeloid progenitor cell_Undefined_Mouse Gene SetFrom CellMarker Gene-Cell Type Associations genes associated with the Common myeloid progenitor cell_Undefined_Mouse cell type from the CellMarker Gene-Cell Type Associations dataset. |
Common lymphoid progenitor cell_Undefined_Mouse Gene SetFrom CellMarker Gene-Cell Type Associations genes associated with the Common lymphoid progenitor cell_Undefined_Mouse cell type from the CellMarker Gene-Cell Type Associations dataset. |
Common pathways underlying drug addiction Gene SetFrom WikiPathways Pathways 2024 proteins participating in the Common pathways underlying drug addiction pathway from the WikiPathways Pathways 2024 dataset. |
Common Pathway of Fibrin Clot Formation Gene Setproteins participating in the Common Pathway of Fibrin Clot Formation pathway from the Reactome Pathways 2024 dataset. |
blood coagulation, common pathway Gene SetFrom GO Biological Process Annotations 2025 genes participating in the blood coagulation, common pathway biological process from the curated GO Biological Process Annotations 2025 dataset. |
negative regulation of blood coagulation, common pathway Gene SetFrom GO Biological Process Annotations 2025 genes participating in the negative regulation of blood coagulation, common pathway biological process from the curated GO Biological Process Annotations 2025 dataset. |
regulation of blood coagulation, common pathway Gene SetFrom GO Biological Process Annotations 2025 genes participating in the regulation of blood coagulation, common pathway biological process from the curated GO Biological Process Annotations 2025 dataset. |
Common bile duct disease Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Common bile duct disease in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Common cold Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Common cold in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Common wart Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Common wart in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Common bile duct neoplasm Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Common bile duct neoplasm in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Common peroneal nerve lesion Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Common peroneal nerve lesion in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Common penile artery Gene SetFrom TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 proteins co-occuring with the tissue Common penile artery in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. |
Common cardinal vein Gene SetFrom TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 proteins co-occuring with the tissue Common cardinal vein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. |
Atrioventricular septal defect and common atrioventricular junction Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Atrioventricular septal defect and common atrioventricular junction phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Common Congenital Anomalies of the Kidney and Urinary Tract Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Common Congenital Anomalies of the Kidney and Urinary Tract phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Common traits (Other) Gene SetFrom GWAS Catalog SNP-Phenotype Associations 2025 genes associated with the Common traits (Other) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. |
Common carotid intima-media thickness in HIV negative individuals Gene SetFrom GWAS Catalog SNP-Phenotype Associations 2025 genes associated with the Common carotid intima-media thickness in HIV negative individuals phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. |
Common carotid intima-media thickness in HIV infection Gene SetFrom GWAS Catalog SNP-Phenotype Associations 2025 genes associated with the Common carotid intima-media thickness in HIV infection phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. |
Common carotid intima-media thickness Gene SetFrom GWAS Catalog SNP-Phenotype Associations 2025 genes associated with the Common carotid intima-media thickness phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. |
PMC9573879-41467_2022_33881_MOESM7_ESM.xlsx-common-Commonly_enriched_proteins_from_EEA1_and_TMEM192_isolates_EEA1 Gene SetFrom Rummagene Transcription Factor Associations 2026 target genes of the PMC9573879-41467_2022_33881_MOESM7_ESM.xlsx-common-Commonly_enriched_proteins_from_EEA1_and_TMEM192_isolates_EEA1 transcription factor from the Rummagene Transcription Factor Associations 2026 dataset. |
PMC9288051-13046_2022_2428_MOESM12_ESM.xlsx-common-common_genes_bound_by_LYL1_at_its_promoter_regions_in_AML_cell_line_NB4_HL-60_and_Kasumi-1_LYL1 Gene SetFrom Rummagene Transcription Factor Associations 2026 target genes of the PMC9288051-13046_2022_2428_MOESM12_ESM.xlsx-common-common_genes_bound_by_LYL1_at_its_promoter_regions_in_AML_cell_line_NB4_HL-60_and_Kasumi-1_LYL1 transcription factor from the Rummagene Transcription Factor Associations 2026 dataset. |
Congenital human immunodeficiency virus Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Congenital human immunodeficiency virus phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Ectodermal dysplasia, anhidrotic, with immunodeficiency, osteopetrosis, and lymphedema Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Ectodermal dysplasia, anhidrotic, with immunodeficiency, osteopetrosis, and lymphedema phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 8 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 8 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
T-cell immunodeficiency, recurrent infections, and autoimmunity with or without cardiac malformations Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the T-cell immunodeficiency, recurrent infections, and autoimmunity with or without cardiac malformations phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
X-linked severe combined immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the X-linked severe combined immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Severe combined immunodeficiency due to ADA deficiency Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Severe combined immunodeficiency due to ADA deficiency phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Facial dysmorphism, immunodeficiency, livedo, and short stature Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Facial dysmorphism, immunodeficiency, livedo, and short stature phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Hepatic venoocclusive disease with immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Hepatic venoocclusive disease with immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Absent corpus callosum cataract immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Absent corpus callosum cataract immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency with hyper IgM type 5 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency with hyper IgM type 5 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency with hyper IgM type 1 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency with hyper IgM type 1 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency with hyper IgM type 3 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency with hyper IgM type 3 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency with hyper IgM type 2 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency with hyper IgM type 2 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
IL21R immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the IL21R immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Neutrophil immunodeficiency syndrome Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Neutrophil immunodeficiency syndrome phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Growth hormone insensitivity with immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Growth hormone insensitivity with immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency due to ficolin 3 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency due to ficolin 3 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Combined immunodeficiency, X-linked Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Combined immunodeficiency, X-linked phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, autosomal dominant Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, autosomal dominant phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Severe combined immunodeficiency, atypical Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Severe combined immunodeficiency, atypical phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 31C Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 31C phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 31a Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 31a phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Severe combined immunodeficiency disease Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Severe combined immunodeficiency disease phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency due to defect in cd3-zeta Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency due to defect in cd3-zeta phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
T-cell immunodeficiency, congenital alopecia and nail dystrophy Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the T-cell immunodeficiency, congenital alopecia and nail dystrophy phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 27b Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 27b phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Severe combined immunodeficiency with sensitivity to ionizing radiation Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Severe combined immunodeficiency with sensitivity to ionizing radiation phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 24 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 24 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 23 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 23 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 22 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 22 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 20 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 20 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 29 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 29 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 28 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 28 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 30 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 30 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 38 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 38 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
CARD11 immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the CARD11 immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Microcephaly, normal intelligence and immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Microcephaly, normal intelligence and immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency-centromeric instability-facial anomalies syndrome 2 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 26 with or without neurologic abnormalities Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 26 with or without neurologic abnormalities phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Sideroblastic anemia with b-cell immunodeficiency, periodic fevers, and developmental delay Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Sideroblastic anemia with b-cell immunodeficiency, periodic fevers, and developmental delay phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 18 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 18 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 19 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 19 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 16 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 16 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 17 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 17 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 15 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 15 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 12 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 12 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Immunodeficiency 13 Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Immunodeficiency 13 phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Polyglucosan body myopathy, early-onset, with or without immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations genes associated with the Polyglucosan body myopathy, early-onset, with or without immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations dataset. |
Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Positive, NK Cell-Negative Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Positive, NK Cell-Negative from the curated CTD Gene-Disease Associations dataset. |
Severe Combined Immunodeficiency with Microcephaly, Growth Retardation, and Sensitivity to Ionizing Radiation Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Severe Combined Immunodeficiency with Microcephaly, Growth Retardation, and Sensitivity to Ionizing Radiation from the curated CTD Gene-Disease Associations dataset. |
Severe Combined Immunodeficiency Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Severe Combined Immunodeficiency from the curated CTD Gene-Disease Associations dataset. |
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1 Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1 from the curated CTD Gene-Disease Associations dataset. |
Ectodermal Dysplasia, Anhidrotic, with Immunodeficiency, Osteopetrosis, and Lymphedema Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Ectodermal Dysplasia, Anhidrotic, with Immunodeficiency, Osteopetrosis, and Lymphedema from the curated CTD Gene-Disease Associations dataset. |
Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive from the curated CTD Gene-Disease Associations dataset. |
Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant from the curated CTD Gene-Disease Associations dataset. |
Hepatic venoocclusive disease with immunodeficiency Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Hepatic venoocclusive disease with immunodeficiency from the curated CTD Gene-Disease Associations dataset. |
Immunodeficiency without anhidrotic ectodermal dysplasia Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Immunodeficiency without anhidrotic ectodermal dysplasia from the curated CTD Gene-Disease Associations dataset. |
Absent corpus callosum cataract immunodeficiency Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Absent corpus callosum cataract immunodeficiency from the curated CTD Gene-Disease Associations dataset. |
Severe combined immunodeficiency due to adenosine deaminase deficiency Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Severe combined immunodeficiency due to adenosine deaminase deficiency from the curated CTD Gene-Disease Associations dataset. |
Neutrophil Immunodeficiency Syndrome Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Neutrophil Immunodeficiency Syndrome from the curated CTD Gene-Disease Associations dataset. |
Hyper-IgM Immunodeficiency Syndrome, Type 1 Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Hyper-IgM Immunodeficiency Syndrome, Type 1 from the curated CTD Gene-Disease Associations dataset. |
T cell immunodeficiency primary Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease T cell immunodeficiency primary from the curated CTD Gene-Disease Associations dataset. |
Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive from the curated CTD Gene-Disease Associations dataset. |
Severe combined immunodeficiency with sensitivity to ionizing radiation Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Severe combined immunodeficiency with sensitivity to ionizing radiation from the curated CTD Gene-Disease Associations dataset. |
Immunodeficiency due to Defect in CD3-Zeta Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Immunodeficiency due to Defect in CD3-Zeta from the curated CTD Gene-Disease Associations dataset. |
Acquired Immunodeficiency Syndrome Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Acquired Immunodeficiency Syndrome from the curated CTD Gene-Disease Associations dataset. |
X-Linked Combined Immunodeficiency Diseases Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease X-Linked Combined Immunodeficiency Diseases from the curated CTD Gene-Disease Associations dataset. |
Hyper-IgM Immunodeficiency Syndrome Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Hyper-IgM Immunodeficiency Syndrome from the curated CTD Gene-Disease Associations dataset. |
Immunodeficiency due to Defect in MAPBP-Interacting Protein Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease Immunodeficiency due to Defect in MAPBP-Interacting Protein from the curated CTD Gene-Disease Associations dataset. |
T-cell immunodeficiency, congenital alopecia and nail dystrophy Gene SetFrom CTD Gene-Disease Associations genes/proteins associated with the disease T-cell immunodeficiency, congenital alopecia and nail dystrophy from the curated CTD Gene-Disease Associations dataset. |
Acquired Immunodeficiency Syndrome Gene SetFrom dbGAP Gene-Trait Associations genes associated with the trait Acquired Immunodeficiency Syndrome in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. |
severe combined immunodeficiency Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores genes involed in the disease severe combined immunodeficiency from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. |
primary immunodeficiency disease Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores genes involed in the disease primary immunodeficiency disease from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. |
combined t cell and b cell immunodeficiency Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores genes involed in the disease combined t cell and b cell immunodeficiency from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. |
primary immunodeficiency disease Gene SetFrom DISEASES Experimental Gene-Disease Association Evidence Scores genes associated with the disease primary immunodeficiency disease in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. |
acquired immunodeficiency syndrome Gene SetFrom DISEASES Experimental Gene-Disease Association Evidence Scores genes associated with the disease acquired immunodeficiency syndrome in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. |
human immunodeficiency virus infectious disease Gene SetFrom DISEASES Experimental Gene-Disease Association Evidence Scores genes associated with the disease human immunodeficiency virus infectious disease in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. |
primary immunodeficiency disease Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores genes co-occuring with the disease primary immunodeficiency disease in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. |
severe combined immunodeficiency Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores genes co-occuring with the disease severe combined immunodeficiency in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. |
acquired immunodeficiency syndrome Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores genes co-occuring with the disease acquired immunodeficiency syndrome in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. |
human immunodeficiency virus infectious disease Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores genes co-occuring with the disease human immunodeficiency virus infectious disease in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. |
combined t cell and b cell immunodeficiency Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores genes co-occuring with the disease combined t cell and b cell immunodeficiency in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. |
carcinoma, squamous cell; conjunctival neoplasms; hiv infections; squamous cell carcinoma; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease carcinoma, squamous cell; conjunctival neoplasms; hiv infections; squamous cell carcinoma; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hiv infections; hiv seropositivity; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hiv infections; hiv seropositivity; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hiv infections; hiv seropositivity; papillomavirus infections; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hiv infections; hiv seropositivity; papillomavirus infections; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
diabetes mellitus, insulin-dependent; diabetes mellitus, type 1; hiv infections; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease diabetes mellitus, insulin-dependent; diabetes mellitus, type 1; hiv infections; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
diabetes mellitus; hiv infections; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease diabetes mellitus; hiv infections; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
acquired immunodeficiency syndrome; cardiovascular diseases Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome; cardiovascular diseases in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hiv infections; pregnancy complications, infectious; viremia; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hiv infections; pregnancy complications, infectious; viremia; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
neutrophil immunodeficiency syndrome Gene SetFrom GAD Gene-Disease Associations genes associated with the disease neutrophil immunodeficiency syndrome in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hiv infections; viremia; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hiv infections; viremia; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hepatitis b; hepatitis c; hiv infections; porphyria cutanea tarda; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hepatitis b; hepatitis c; hiv infections; porphyria cutanea tarda; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hiv infections; tuberculosis; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hiv infections; tuberculosis; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
acquired immunodeficiency syndrome; Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome; in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
acquired immunodeficiency syndrome; aids dementia complex; aids related dementia complex; disease progression Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome; aids dementia complex; aids related dementia complex; disease progression in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hiv infections; pregnancy complications, infectious; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hiv infections; pregnancy complications, infectious; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hiv infections; hyperbilirubinemia; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hiv infections; hyperbilirubinemia; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
dyslipidemias; hiv infections; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease dyslipidemias; hiv infections; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
acquired immunodeficiency syndrome; aids-related opportunistic infections; cytomegalovirus retinitis; Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome; aids-related opportunistic infections; cytomegalovirus retinitis; in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
drug hypersensitivity; hiv infections; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease drug hypersensitivity; hiv infections; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hepatitis c; hiv infections; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hepatitis c; hiv infections; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
aids-related opportunistic infections; hiv infections; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease aids-related opportunistic infections; hiv infections; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hiv infections; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hiv infections; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hiv infections; substance abuse, intravenous; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hiv infections; substance abuse, intravenous; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hiv infections; hiv-associated lipodystrophy syndrome; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hiv infections; hiv-associated lipodystrophy syndrome; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
ahg deficiency disease; hemophilia a; hiv infections; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease ahg deficiency disease; hemophilia a; hiv infections; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
acquired immunodeficiency syndrome; hiv infections Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome; hiv infections in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
acquired immunodeficiency syndrome; disease progression Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome; disease progression in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
lymphopenia; scid; severe combined immunodeficiency Gene SetFrom GAD Gene-Disease Associations genes associated with the disease lymphopenia; scid; severe combined immunodeficiency in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
acquired immunodeficiency syndrome; substance abuse, intravenous Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome; substance abuse, intravenous in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hepatitis c, chronic; hiv infections; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hepatitis c, chronic; hiv infections; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
acquired immunodeficiency syndrome Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hiv infections; lipodystrophy; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hiv infections; lipodystrophy; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
x-linked severe combined immunodeficiency Gene SetFrom GAD Gene-Disease Associations genes associated with the disease x-linked severe combined immunodeficiency in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
acquired immunodeficiency syndrome; tuberculosis, pulmonary Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome; tuberculosis, pulmonary in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
acquired immunodeficiency syndrome; hiv seropositivity Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome; hiv seropositivity in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
increased perinatal immunodeficiency virus type 1 transmission Gene SetFrom GAD Gene-Disease Associations genes associated with the disease increased perinatal immunodeficiency virus type 1 transmission in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
central nervous system neoplasms; central nervous system tumors; hiv infections; lymphoma, aids-related; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease central nervous system neoplasms; central nervous system tumors; hiv infections; lymphoma, aids-related; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
ahg deficiency disease; hemophilia a; hepatitis c; hiv infections; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease ahg deficiency disease; hemophilia a; hepatitis c; hiv infections; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
acquired immunodeficiency syndrome; kaposi sarcoma; lymphoma, aids-related; sarcoma, kaposi Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome; kaposi sarcoma; lymphoma, aids-related; sarcoma, kaposi in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
aids-related opportunistic infections; cytomegalovirus retinitis; encephalomyelitis; hiv infections; hypersensitivity; mycobacterium avium-intracellulare infection; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease aids-related opportunistic infections; cytomegalovirus retinitis; encephalomyelitis; hiv infections; hypersensitivity; mycobacterium avium-intracellulare infection; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hemochromatosis; hepatitis c; hiv infections; porphyria cutanea tarda; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hemochromatosis; hepatitis c; hiv infections; porphyria cutanea tarda; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
candidiasis, oral; hiv infections; oral candidiasis; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease candidiasis, oral; hiv infections; oral candidiasis; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hemochromatosis; hiv infections; peripheral nervous system diseases; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hemochromatosis; hiv infections; peripheral nervous system diseases; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
ahg deficiency disease; hemophilia a; hiv infections; sexually transmitted diseases, viral; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease ahg deficiency disease; hemophilia a; hiv infections; sexually transmitted diseases, viral; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hiv infections; hyperlipidemias; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hiv infections; hyperlipidemias; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
autosomal dominant anhidrotic ectodermal dysplasia and t cell immunodeficiency Gene SetFrom GAD Gene-Disease Associations genes associated with the disease autosomal dominant anhidrotic ectodermal dysplasia and t cell immunodeficiency in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
immunologic deficiency syndromes; severe combined immunodeficiency Gene SetFrom GAD Gene-Disease Associations genes associated with the disease immunologic deficiency syndromes; severe combined immunodeficiency in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hepatitis c; hepatitis c, chronic; hiv infections; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hepatitis c; hepatitis c, chronic; hiv infections; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
hiv infections; hypersensitivity, delayed; [x]human immunodeficiency virus disease Gene SetFrom GAD Gene-Disease Associations genes associated with the disease hiv infections; hypersensitivity, delayed; [x]human immunodeficiency virus disease in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
acquired immunodeficiency syndrome; aids-related opportunistic infections; cytomegalovirus retinitis Gene SetFrom GAD Gene-Disease Associations genes associated with the disease acquired immunodeficiency syndrome; aids-related opportunistic infections; cytomegalovirus retinitis in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. |
immunodeficiency Gene SetFrom GeneRIF Biological Term Annotations genes co-occuring with the biological term immunodeficiency in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. |
HIV - Human immunodeficiency virus infection_T lymphocyte_GSE2504 Gene SetFrom GEO Signatures of Differentially Expressed Genes for Diseases genes differentially expressed during HIV - Human immunodeficiency virus infection_T lymphocyte_GSE2504 disease perturbation from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. |
HIV - Human immunodeficiency virus infection_Peripheral blood mononuclear cell_GSE2171 Gene SetFrom GEO Signatures of Differentially Expressed Genes for Diseases genes differentially expressed during HIV - Human immunodeficiency virus infection_Peripheral blood mononuclear cell_GSE2171 disease perturbation from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. |
HIV - Human immunodeficiency virus infection_T lymphocyte_GSE6740 Gene SetFrom GEO Signatures of Differentially Expressed Genes for Diseases genes differentially expressed during HIV - Human immunodeficiency virus infection_T lymphocyte_GSE6740 disease perturbation from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. |
primary immunodeficiency disease Gene SetFrom GWASdb SNP-Disease Associations genes associated with the disease primary immunodeficiency disease in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. |
acquired immunodeficiency syndrome Gene SetFrom GWASdb SNP-Disease Associations genes associated with the disease acquired immunodeficiency syndrome in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. |
human immunodeficiency virus infectious disease Gene SetFrom GWASdb SNP-Disease Associations genes associated with the disease human immunodeficiency virus infectious disease in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. |
immunodeficiency Gene SetFrom GWASdb SNP-Phenotype Associations genes associated with the immunodeficiency phenotype in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. |
osteomyelitis due to immunodeficiency Gene SetFrom HPO Gene-Disease Associations genes associated with the osteomyelitis due to immunodeficiency phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. |
severe t-cell immunodeficiency Gene SetFrom HPO Gene-Disease Associations genes associated with the severe t-cell immunodeficiency phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. |
severe combined immunodeficiency Gene SetFrom HPO Gene-Disease Associations genes associated with the severe combined immunodeficiency phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. |
combined immunodeficiency Gene SetFrom HPO Gene-Disease Associations genes associated with the combined immunodeficiency phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. |
immunodeficiency Gene SetFrom HPO Gene-Disease Associations genes associated with the immunodeficiency phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. |
cellular immunodeficiency Gene SetFrom HPO Gene-Disease Associations genes associated with the cellular immunodeficiency phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. |
hepatic abscesses due to immunodeficiency Gene SetFrom HPO Gene-Disease Associations genes associated with the hepatic abscesses due to immunodeficiency phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. |
cellulitis due to immunodeficiency Gene SetFrom HPO Gene-Disease Associations genes associated with the cellulitis due to immunodeficiency phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. |
Simian Acquired Immunodeficiency Syndrome Gene SetFrom HuGE Navigator Gene-Phenotype Associations genes associated with the Simian Acquired Immunodeficiency Syndrome phenotype by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. |
Severe Combined Immunodeficiency Gene SetFrom HuGE Navigator Gene-Phenotype Associations genes associated with the Severe Combined Immunodeficiency phenotype by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. |
Acquired Immunodeficiency Syndrome Gene SetFrom HuGE Navigator Gene-Phenotype Associations genes associated with the Acquired Immunodeficiency Syndrome phenotype by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. |
Immunodeficiency virus transactivating regulatory protein (Tat) Gene SetFrom InterPro Predicted Protein Domain Annotations proteins predicted to have the Immunodeficiency virus transactivating regulatory protein (Tat) protein domain from the InterPro Predicted Protein Domain Annotations dataset. |
?immunodeficiency 37 Gene SetFrom OMIM Gene-Disease Associations genes associated with the ?immunodeficiency 37 phenotype from the curated OMIM Gene-Disease Associations dataset. |
neutrophil immunodeficiency syndrome Gene SetFrom OMIM Gene-Disease Associations genes associated with the neutrophil immunodeficiency syndrome phenotype from the curated OMIM Gene-Disease Associations dataset. |
severe combined immunodeficiency due to il2 deficiency Gene SetFrom OMIM Gene-Disease Associations genes associated with the severe combined immunodeficiency due to il2 deficiency phenotype from the curated OMIM Gene-Disease Associations dataset. |
ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency Gene SetFrom OMIM Gene-Disease Associations genes associated with the ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 31a, mycobacteriosis, autosomal dominant Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 31a, mycobacteriosis, autosomal dominant phenotype from the curated OMIM Gene-Disease Associations dataset. |
t-cell immunodeficiency, congenital alopecia, and nail dystrophy Gene SetFrom OMIM Gene-Disease Associations genes associated with the t-cell immunodeficiency, congenital alopecia, and nail dystrophy phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency, x-linked, with hyper-igm Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency, x-linked, with hyper-igm phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency, isolated Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency, isolated phenotype from the curated OMIM Gene-Disease Associations dataset. |
hepatic venoocclusive disease with immunodeficiency Gene SetFrom OMIM Gene-Disease Associations genes associated with the hepatic venoocclusive disease with immunodeficiency phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 24 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 24 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 23 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 23 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 20 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 20 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 27b, mycobacteriosis, ad Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 27b, mycobacteriosis, ad phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 14 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 14 phenotype from the curated OMIM Gene-Disease Associations dataset. |
t-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations Gene SetFrom OMIM Gene-Disease Associations genes associated with the t-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency due to purine nucleoside phosphorylase deficiency Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency due to purine nucleoside phosphorylase deficiency phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 31b, mycobacterial and viral infections, autosomal recessive Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 31b, mycobacterial and viral infections, autosomal recessive phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency-centromeric instability-facial anomalies syndrome-2 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency-centromeric instability-facial anomalies syndrome-2 phenotype from the curated OMIM Gene-Disease Associations dataset. |
ectodermal dysplasia, anhidrotic, with t-cell immunodeficiency Gene SetFrom OMIM Gene-Disease Associations genes associated with the ectodermal dysplasia, anhidrotic, with t-cell immunodeficiency phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 36 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 36 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 32b, monocyte and dendritic cell deficiency, autosomal recessive Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 32b, monocyte and dendritic cell deficiency, autosomal recessive phenotype from the curated OMIM Gene-Disease Associations dataset. |
growth hormone insensitivity with immunodeficiency Gene SetFrom OMIM Gene-Disease Associations genes associated with the growth hormone insensitivity with immunodeficiency phenotype from the curated OMIM Gene-Disease Associations dataset. |
severe combined immunodeficiency, t cell-negative, b-cell/natural killer-cell positive Gene SetFrom OMIM Gene-Disease Associations genes associated with the severe combined immunodeficiency, t cell-negative, b-cell/natural killer-cell positive phenotype from the curated OMIM Gene-Disease Associations dataset. |
severe combined immunodeficiency due to ada deficiency Gene SetFrom OMIM Gene-Disease Associations genes associated with the severe combined immunodeficiency due to ada deficiency phenotype from the curated OMIM Gene-Disease Associations dataset. |
?immunodeficiency 9 Gene SetFrom OMIM Gene-Disease Associations genes associated with the ?immunodeficiency 9 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 8 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 8 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency, primary, autosomal recessive, il21r-related Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency, primary, autosomal recessive, il21r-related phenotype from the curated OMIM Gene-Disease Associations dataset. |
?immunodeficiency 25 Gene SetFrom OMIM Gene-Disease Associations genes associated with the ?immunodeficiency 25 phenotype from the curated OMIM Gene-Disease Associations dataset. |
?immunodeficiency 22 Gene SetFrom OMIM Gene-Disease Associations genes associated with the ?immunodeficiency 22 phenotype from the curated OMIM Gene-Disease Associations dataset. |
polyglucosan body myopathy, early-onset, with or without immunodeficiency Gene SetFrom OMIM Gene-Disease Associations genes associated with the polyglucosan body myopathy, early-onset, with or without immunodeficiency phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 17, cd3 gamma deficient Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 17, cd3 gamma deficient phenotype from the curated OMIM Gene-Disease Associations dataset. |
combined immunodeficiency, x-linked, moderate Gene SetFrom OMIM Gene-Disease Associations genes associated with the combined immunodeficiency, x-linked, moderate phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency with hyper-igm, type 3 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency with hyper-igm, type 3 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency with hyper-igm, type 2 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency with hyper-igm, type 2 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 29, mycobacteriosis Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 29, mycobacteriosis phenotype from the curated OMIM Gene-Disease Associations dataset. |
severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation Gene SetFrom OMIM Gene-Disease Associations genes associated with the severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 35 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 35 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 30 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 30 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 33 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 33 phenotype from the curated OMIM Gene-Disease Associations dataset. |
severe combined immunodeficiency, b cell-negative Gene SetFrom OMIM Gene-Disease Associations genes associated with the severe combined immunodeficiency, b cell-negative phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 34, mycobacteriosis, x-linked Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 34, mycobacteriosis, x-linked phenotype from the curated OMIM Gene-Disease Associations dataset. |
severe combined immunodeficiency, athabascan type Gene SetFrom OMIM Gene-Disease Associations genes associated with the severe combined immunodeficiency, athabascan type phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 18 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 18 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 19 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 19 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 15 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 15 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 12 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 12 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 10 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 10 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 11 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 11 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 31c, autosomal dominant Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 31c, autosomal dominant phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 18, scid variant Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 18, scid variant phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency with hyper igm, type 5 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency with hyper igm, type 5 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 32a, mycobacteriosis, autosomal dominant Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 32a, mycobacteriosis, autosomal dominant phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 27a, mycobacteriosis, ar Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 27a, mycobacteriosis, ar phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency-centromeric instability-facial anomalies syndrome 1 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency-centromeric instability-facial anomalies syndrome 1 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency due to defect in mapbp-interacting protein Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency due to defect in mapbp-interacting protein phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 7, tcr-alpha/beta deficient Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 7, tcr-alpha/beta deficient phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency, x-linked, with magnesium defect, epstein-barr virus infection and neoplasia Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency, x-linked, with magnesium defect, epstein-barr virus infection and neoplasia phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency due to ficolin 3 deficiency Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency due to ficolin 3 deficiency phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 28, mycobacteriosis Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 28, mycobacteriosis phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 16, with or without neurologic abnormalities Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 16, with or without neurologic abnormalities phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 21 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 21 phenotype from the curated OMIM Gene-Disease Associations dataset. |
severe combined immunodeficiency, t-cell negative, b-cell/natural killer cell-positive type Gene SetFrom OMIM Gene-Disease Associations genes associated with the severe combined immunodeficiency, t-cell negative, b-cell/natural killer cell-positive type phenotype from the curated OMIM Gene-Disease Associations dataset. |
severe combined immunodeficiency, x-linked Gene SetFrom OMIM Gene-Disease Associations genes associated with the severe combined immunodeficiency, x-linked phenotype from the curated OMIM Gene-Disease Associations dataset. |
sideroblastic anemia with b-cell immunodeficiency, periodic fevers, and developmental delay Gene SetFrom OMIM Gene-Disease Associations genes associated with the sideroblastic anemia with b-cell immunodeficiency, periodic fevers, and developmental delay phenotype from the curated OMIM Gene-Disease Associations dataset. |
?immunodeficiency 16 Gene SetFrom OMIM Gene-Disease Associations genes associated with the ?immunodeficiency 16 phenotype from the curated OMIM Gene-Disease Associations dataset. |
?immunodeficiency 13 Gene SetFrom OMIM Gene-Disease Associations genes associated with the ?immunodeficiency 13 phenotype from the curated OMIM Gene-Disease Associations dataset. |
immunodeficiency 38 Gene SetFrom OMIM Gene-Disease Associations genes associated with the immunodeficiency 38 phenotype from the curated OMIM Gene-Disease Associations dataset. |
Human immunodeficiency virus type 1 (isolate HXB3) Gene SetFrom Virus MINT Protein-Virus Interactions interacting proteins for the virus Human immunodeficiency virus type 1 (isolate HXB3) from the Virus MINT Protein-Virus Interactions dataset. |
Human immunodeficiency virus type 1 (isolate ELI) Gene SetFrom Virus MINT Protein-Virus Interactions interacting proteins for the virus Human immunodeficiency virus type 1 (isolate ELI) from the Virus MINT Protein-Virus Interactions dataset. |
Human immunodeficiency virus type 1 group M subtype B (isolate MN) Gene SetFrom Virus MINT Protein-Virus Interactions interacting proteins for the virus Human immunodeficiency virus type 1 group M subtype B (isolate MN) from the Virus MINT Protein-Virus Interactions dataset. |
Human immunodeficiency virus type 1 (isolate ARV2/SF2) Gene SetFrom Virus MINT Protein-Virus Interactions interacting proteins for the virus Human immunodeficiency virus type 1 (isolate ARV2/SF2) from the Virus MINT Protein-Virus Interactions dataset. |
Human immunodeficiency virus type 1 (isolate 12) Gene SetFrom Virus MINT Protein-Virus Interactions interacting proteins for the virus Human immunodeficiency virus type 1 (isolate 12) from the Virus MINT Protein-Virus Interactions dataset. |
Human immunodeficiency virus 1 Gene SetFrom Virus MINT Protein-Virus Interactions interacting proteins for the virus Human immunodeficiency virus 1 from the Virus MINT Protein-Virus Interactions dataset. |
Human immunodeficiency virus type 1 (isolate Lai) Gene SetFrom Virus MINT Protein-Virus Interactions interacting proteins for the virus Human immunodeficiency virus type 1 (isolate Lai) from the Virus MINT Protein-Virus Interactions dataset. |
Human Immunodeficiency Virus Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Human Immunodeficiency Virus in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Severe Combined Immunodeficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Severe Combined Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Humoral Immunodeficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Humoral Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Combined Immunodeficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Combined Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Adult-Onset Immunodeficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Adult-Onset Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Combined Immunodeficiency Disease Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Combined Immunodeficiency Disease in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
T-Lymphocyte Immunodeficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease T-Lymphocyte Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Immunodeficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Asymptomatic Human Immunodeficiency Virus Infection Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Asymptomatic Human Immunodeficiency Virus Infection in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Pediatric Human Immunodeficiency Virus Infection Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Pediatric Human Immunodeficiency Virus Infection in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Hyper-Igm Immunodeficiency Syndrome Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Hyper-Igm Immunodeficiency Syndrome in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Hypopigmentation-Immunodeficiency Disease Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Hypopigmentation-Immunodeficiency Disease in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Hyper-Igm Immunodeficiency, X-Linked, With Ectodermal Dysplasia, Hypohidrotic Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Hyper-Igm Immunodeficiency, X-Linked, With Ectodermal Dysplasia, Hypohidrotic in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Acquired Immunodeficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Acquired Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Athabaskan Severe Combined Immunodeficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Athabaskan Severe Combined Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Absent Corpus Callosum Cataract Immunodeficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Absent Corpus Callosum Cataract Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Lung Disease, Immunodeficiency, And Chromosome Breakage Syndrome Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Lung Disease, Immunodeficiency, And Chromosome Breakage Syndrome in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Severe T-Cell Immunodeficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Severe T-Cell Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
T-Cell Immunodeficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease T-Cell Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Acquired Immunodeficiency Syndrome Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Acquired Immunodeficiency Syndrome in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Primary Immunodeficiency Syndrome Due To P14 Deficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Primary Immunodeficiency Syndrome Due To P14 Deficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Combined Immunodeficiency And Megaloblastic Anemia With Or Without Hyperhomocysteinemia Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Combined Immunodeficiency And Megaloblastic Anemia With Or Without Hyperhomocysteinemia in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Facial Dysmorphism, Immunodeficiency, Livedo, And Short Stature Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Facial Dysmorphism, Immunodeficiency, Livedo, And Short Stature in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Neutrophil Immunodeficiency Syndrome Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Neutrophil Immunodeficiency Syndrome in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Phagocytic Immunodeficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Phagocytic Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Polyglucosan Body Myopathy 1 With Or Without Immunodeficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Polyglucosan Body Myopathy 1 With Or Without Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
B-Cell Immunodeficiency, Distal Limb Anomalies, And Urogenital Malformations Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease B-Cell Immunodeficiency, Distal Limb Anomalies, And Urogenital Malformations in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Hepatic Venoocclusive Disease With Immunodeficiency Gene SetFrom DisGeNET Gene-Disease Associations genes associated with the disease Hepatic Venoocclusive Disease With Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. |
Acquired Immunodeficiency Syndrome Gene SetFrom DisGeNET Gene-Phenotype Associations genes associated with the phenotype Acquired Immunodeficiency Syndrome in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset. |
Cellular Immunodeficiency Gene SetFrom DisGeNET Gene-Phenotype Associations genes associated with the phenotype Cellular Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset. |
Human Immunodeficiency Virus Gene SetFrom DisGeNET Gene-Phenotype Associations genes associated with the phenotype Human Immunodeficiency Virus in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset. |
Immunodeficiency Gene SetFrom DisGeNET Gene-Phenotype Associations genes associated with the phenotype Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset. |
T-Cell Immunodeficiency Gene SetFrom DisGeNET Gene-Phenotype Associations genes associated with the phenotype T-Cell Immunodeficiency in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset. |
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) Gene Setproteins participating in the IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) pathway from the Reactome Pathways 2024 dataset. |
Primary immunodeficiency disease Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores 2025 genes involed in the disease Primary immunodeficiency disease from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. |
Severe combined immunodeficiency Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores 2025 genes involed in the disease Severe combined immunodeficiency from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. |
Combined immunodeficiency Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores 2025 genes involed in the disease Combined immunodeficiency from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. |
Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores 2025 genes involed in the disease Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. |
Hepatic venoocclusive disease with immunodeficiency Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores 2025 genes involed in the disease Hepatic venoocclusive disease with immunodeficiency from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. |
Combined T cell and B cell immunodeficiency Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores 2025 genes involed in the disease Combined T cell and B cell immunodeficiency from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. |
Immunodeficiency 23 Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores 2025 genes involed in the disease Immunodeficiency 23 from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. |
Immunodeficiency 14 Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores 2025 genes involed in the disease Immunodeficiency 14 from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. |
T-cell immunodeficiency, congenital alopecia, and nail dystrophy Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores 2025 genes involed in the disease T-cell immunodeficiency, congenital alopecia, and nail dystrophy from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. |
X-linked severe combined immunodeficiency Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores 2025 genes involed in the disease X-linked severe combined immunodeficiency from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores 2025 genes involed in the disease X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. |
Immunodeficiency 48 Gene SetFrom DISEASES Curated Gene-Disease Association Evidence Scores 2025 genes involed in the disease Immunodeficiency 48 from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. |
Primary immunodeficiency disease Gene SetFrom DISEASES Experimental Gene-Disease Association Evidence Scores 2025 genes associated with the disease Primary immunodeficiency disease in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. |
Human immunodeficiency virus infectious disease Gene SetFrom DISEASES Experimental Gene-Disease Association Evidence Scores 2025 genes associated with the disease Human immunodeficiency virus infectious disease in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. |
Acquired immunodeficiency syndrome Gene SetFrom DISEASES Experimental Gene-Disease Association Evidence Scores 2025 genes associated with the disease Acquired immunodeficiency syndrome in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 72 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 72 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 43 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 43 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Primary immunodeficiency disease Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Primary immunodeficiency disease in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 40 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 40 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency with hyper-IgM type 2 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency with hyper-IgM type 2 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Human immunodeficiency virus infectious disease Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Human immunodeficiency virus infectious disease in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Acquired immunodeficiency syndrome Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Acquired immunodeficiency syndrome in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Combined immunodeficiency Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Combined immunodeficiency in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Severe combined immunodeficiency Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Severe combined immunodeficiency in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Combined T cell and B cell immunodeficiency Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Combined T cell and B cell immunodeficiency in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
X-linked severe combined immunodeficiency Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease X-linked severe combined immunodeficiency in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 21 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 21 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 14 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 14 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 13 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 13 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 10 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 10 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
T cell and NK cell immunodeficiency Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease T cell and NK cell immunodeficiency in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 41 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 41 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency with hyper IgM type 3 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency with hyper IgM type 3 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 73a with defective neutrophil chemotaxis and leukocytosis Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 73a with defective neutrophil chemotaxis and leukocytosis in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 51 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 51 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 28 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 28 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 16 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 16 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 35 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 35 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
X-Linked immunodeficiency 74 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease X-Linked immunodeficiency 74 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Severe combined immunodeficiency with sensitivity to ionizing radiation Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Severe combined immunodeficiency with sensitivity to ionizing radiation in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 11A Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 11A in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
immunodeficiency-centromeric instability-facial anomalies syndrome Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease immunodeficiency-centromeric instability-facial anomalies syndrome in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 50 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 50 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 63 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 63 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 36 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 36 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 32B Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 32B in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 18 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 18 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 23 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 23 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 48 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 48 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 9 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 9 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 7 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 7 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 54 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 54 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
T-cell immunodeficiency, congenital alopecia, and nail dystrophy Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease T-cell immunodeficiency, congenital alopecia, and nail dystrophy in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency with hyper-IgM type 4 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency with hyper-IgM type 4 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 24 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 24 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 44 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 44 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
immunodeficiency-centromeric instability-facial anomalies syndrome 1 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease immunodeficiency-centromeric instability-facial anomalies syndrome 1 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 29 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 29 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 30 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 30 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Hepatic venoocclusive disease with immunodeficiency Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Hepatic venoocclusive disease with immunodeficiency in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 27B Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 27B in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 31B Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 31B in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 33 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 33 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 71 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 71 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 20 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 20 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 11B Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 11B in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 60 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 60 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 39 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 39 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 38 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 38 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 15A Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 15A in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Ectodermal dysplasia and immunodeficiency 1 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Ectodermal dysplasia and immunodeficiency 1 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 15B Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 15B in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 17 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 17 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 26 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 26 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 57 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 57 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 58 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 58 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency with hyper IgM type 5 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency with hyper IgM type 5 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Ectodermal dysplasia and immunodeficiency 2 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Ectodermal dysplasia and immunodeficiency 2 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 12 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 12 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 31A Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 31A in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 55 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 55 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 65 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 65 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 31C Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 31C in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 47 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 47 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 52 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 52 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 32A Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 32A in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 49 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 49 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 27A Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 27A in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
immunodeficiency-centromeric instability-facial anomalies syndrome 2 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease immunodeficiency-centromeric instability-facial anomalies syndrome 2 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 53 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 53 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 25 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 25 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 34 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 34 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 46 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 46 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 22 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 22 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 45 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 45 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 61 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 61 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Immunodeficiency 19 Gene SetFrom DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 genes co-occuring with the disease Immunodeficiency 19 in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. |
Severe combined immunodeficiency disease Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Severe combined immunodeficiency disease phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Severe combined immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Severe combined immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Severe combined immunodeficiency due to DCLRE1C deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Severe combined immunodeficiency due to DCLRE1C deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Athabaskan severe combined immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Athabaskan severe combined immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency due to ficolin3 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency due to ficolin3 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Hepatic veno-occlusive disease-immunodeficiency syndrome Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Hepatic veno-occlusive disease-immunodeficiency syndrome phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency-centromeric instability-facial anomalies syndrome Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency-centromeric instability-facial anomalies syndrome phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
T-cell immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the T-cell immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
T-B+ severe combined immunodeficiency due to JAK3 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the T-B+ severe combined immunodeficiency due to JAK3 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
X-linked severe combined immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the X-linked severe combined immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Combined immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Combined immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Inherited Immunodeficiency diseases Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Inherited Immunodeficiency diseases phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Combined immunodeficiency due to CD3gamma deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Combined immunodeficiency due to CD3gamma deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Combined immunodeficiency due to partial RAG1 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Combined immunodeficiency due to partial RAG1 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Combined immunodeficiency due to ZAP70 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Combined immunodeficiency due to ZAP70 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
ZAP70-Related Severe Combined Immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the ZAP70-Related Severe Combined Immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Combined immunodeficiency and megaloblastic anemia Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Combined immunodeficiency and megaloblastic anemia phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Autosomal recessive primary immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Autosomal recessive primary immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Combined immunodeficiency due to LRBA deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Combined immunodeficiency due to LRBA deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Atypical severe combined immunodeficiency due to complete RAG1/2 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Atypical severe combined immunodeficiency due to complete RAG1/2 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Primary immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Primary immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Combined immunodeficiency due to STK4 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Combined immunodeficiency due to STK4 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Facial dysmorphism-immunodeficiency-livedo-short stature syndrome Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Facial dysmorphism-immunodeficiency-livedo-short stature syndrome phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Combined immunodeficiency due to STIM1 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Combined immunodeficiency due to STIM1 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Severe combined immunodeficiency due to CARD11 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Severe combined immunodeficiency due to CARD11 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Gastrointestinal defects and immunodeficiency syndrome Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Gastrointestinal defects and immunodeficiency syndrome phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Gastrointestinal defect and immunodeficiency syndrome Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Gastrointestinal defect and immunodeficiency syndrome phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Ectodermal dysplasia and immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Ectodermal dysplasia and immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Combined immunodeficiency due to DOCK8 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Combined immunodeficiency due to DOCK8 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency 14b Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency 14b phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
X-linked immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the X-linked immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency 11b Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency 11b phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Neutrophil immunodeficiency syndrome Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Neutrophil immunodeficiency syndrome phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency 73b Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency 73b phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency 73c Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency 73c phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Severe combined immunodeficiency due to CTPS1 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Severe combined immunodeficiency due to CTPS1 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Combined immunodeficiency due to ORAI1 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Combined immunodeficiency due to ORAI1 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency due to CD25 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency due to CD25 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
HUMAN IMMUNODEFICIENCY VIRUS DEMEN Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the HUMAN IMMUNODEFICIENCY VIRUS DEMEN phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Severe combined immunodeficiency due to CARMIL2 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Severe combined immunodeficiency due to CARMIL2 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency due to MASP-2 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency due to MASP-2 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency due to defect in CD3-gamma Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency due to defect in CD3-gamma phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Combined immunodeficiency due to moesin deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Combined immunodeficiency due to moesin deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Severe combined immunodeficiency due to DNA-PKcs deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Severe combined immunodeficiency due to DNA-PKcs deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Severe combined immunodeficiency due to CORO1A deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Severe combined immunodeficiency due to CORO1A deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Combined immunodeficiency due to OX40 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Combined immunodeficiency due to OX40 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Severe combined immunodeficiency due to IKK2 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Severe combined immunodeficiency due to IKK2 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency 15a Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency 15a phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Combined immunodeficiency due to MALT1 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Combined immunodeficiency due to MALT1 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Severe combined immunodeficiency due to LCK deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Severe combined immunodeficiency due to LCK deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency due to a late component of complement deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency due to a late component of complement deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
FADD-related immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the FADD-related immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Primary immunodeficiency syndrome due to p14 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Primary immunodeficiency syndrome due to p14 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency and Autoimmune Enterocolopathy Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency and Autoimmune Enterocolopathy phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
TFRC-related combined immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the TFRC-related combined immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Severe combined immunodeficiency due to LAT deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Severe combined immunodeficiency due to LAT deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
B-cell immunodeficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the B-cell immunodeficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Combined immunodeficiency due to GINS1 deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Combined immunodeficiency due to GINS1 deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency due to purine nucleoside phosphorylase deficiency Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency due to purine nucleoside phosphorylase deficiency phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency 87 and autoimmunity Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency 87 and autoimmunity phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency 85 and autoimmunity Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency 85 and autoimmunity phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Hatipoglu immunodeficiency syndrome Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Hatipoglu immunodeficiency syndrome phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency 89 and autoimmunity Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency 89 and autoimmunity phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Immunodeficiency 91 and hyperinflammation Gene SetFrom ClinVar Gene-Phenotype Associations 2025 genes associated with the Immunodeficiency 91 and hyperinflammation phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset. |
Virion - Human immunodeficiency virus Gene SetFrom KEGG Pathways 2026 proteins participating in the Virion - Human immunodeficiency virus pathway from the KEGG Pathways 2026 dataset. |
Human immunodeficiency virus 1 infection Gene SetFrom KEGG Pathways 2026 proteins participating in the Human immunodeficiency virus 1 infection pathway from the KEGG Pathways 2026 dataset. |
Primary immunodeficiency Gene SetFrom KEGG Pathways 2026 proteins participating in the Primary immunodeficiency pathway from the KEGG Pathways 2026 dataset. |